Siong25 personal page - To The Moon

Siong25

Siong25

No personal profile

159Follow

4Followers

0Topic

0Badge

2021-07-23

China always learn when they copy others country and they will turn the technology into a new way of transform.

Sorry, the original content has been removed

2021-08-01

Just buy it if you bhad strong conviction on SKLz

Upcoming Earnings Could Bring Back Positive Sentiment for Skillz

2021-07-18

Thanks for sharing

Sorry, the original content has been removed

2021-09-02

$Tiger Brokers(TIGR)$karching

2021-07-23

This is too risky for investment, this is gambling

Sorry, the original content has been removed

2021-07-23

China is looking in a long term view. Fabulous

Sorry, the original content has been removed

2021-07-18

Good news

Pfizer is making the case for COVID-19 booster shots. Fauci say we don't need a third dose yet. Who's right?

2021-07-21

Fabulous

Here Is The One-Word Reason Why JPMorgan Just Raised Its S&P Target To 4,600

2023-08-25

Great ariticle, would you like to share it?

Sorry, the original content has been removed

04-17

Share your opinion about this news…

Sorry, the original content has been removed

2021-09-22

Hi here is the TA sharing regarding FVRR.From MACD line showing it uptrend. It could be a bullish if the MACD line break the zero reference.Currently the RSI at around 62. It means not too late to buy some share as a start up.If you see from the chart, the first support price range is around 190-200; second support price range is 155-165.And you put in EMA 100 Or 200, it will be shown the share still considered under value from TA basic.Strategy could be taken1)Sell put to get some premium as a start up to buy some share as a start up position. 2) Buy Call ATM -3 since it still at support level.( Do this only you had a strong conviction)

2023-11-22

$NVIDIA Corp(NVDA)$

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3564653723071869","uuid":"3564653723071869","gmtCreate":1601561010982,"gmtModify":1704447500657,"name":"Siong25","pinyin":"siong25","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":159,"tweetSize":13,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.11.10","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.05%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.16%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":1,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":296233428578472,"gmtCreate":1713342796503,"gmtModify":1713342799753,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"Share your opinion about this news…","listText":"Share your opinion about this news…","text":"Share your opinion about this news…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/296233428578472","repostId":"1189337221","repostType":2,"repost":{"id":"1189337221","kind":"news","pubTimestamp":1713341007,"share":"https://ttm.financial/m/news/1189337221?lang=&edition=fundamental","pubTime":"2024-04-17 16:03","market":"us","language":"en","title":"Tesla's Megapack Plant in Shanghai to Begin Construction in May, Mass Production in Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1189337221","media":"CnEVPost","summary":"The Megafactory will be Tesla's first energy storage system factory outside of its US domestic market, with an initial planned annual production capacity of up to 10,000 commercial energy storage batt","content":"<html><head></head><body><ul style=\"\"><li><p style=\"text-align: left;\">The Megafactory will be Tesla&#39;s first energy storage system factory outside of its US domestic market, with an initial planned annual production capacity of up to 10,000 commercial energy storage batteries.</p></li></ul><p>Tesla&#39;s Megapack factory in Shanghai is scheduled to start construction in May and begin mass production in the first quarter of 2025, local media outlet The Paper said in a report today, citing sources at Tesla China.</p><p>Tesla shares gained 0.81% in premarket trading on Wednesday.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/982b91229e636d820ba7af82d04ac0bb\" tg-width=\"783\" tg-height=\"618\"/></p><p style=\"text-align: left;\">Tesla&#39;s energy storage business has grown at a rapid pace in recent years, with installed capacity reaching 14.7 GWh in 2023, up 125 percent year-on-year, the report noted.</p><p>The latest timeline reported is a delay from the previously announced plan.</p><p>Tesla signed an agreement with Shanghai&#39;s Lingang authorities on April 9, 2023, to build a new Megafactory in the area, which will be dedicated to the production of the energy storage product Megapack.</p><p style=\"text-align: left;\">The Megafactory will be Tesla&#39;s first energy storage system factory outside of its US domestic market. It&#39;s initially planned to produce up to 10,000 commercial energy storage batteries per year, with nearly 40 GWh of energy storage, and the products will be available to the global market.</p><p style=\"text-align: left;\">Construction of the plant was scheduled to begin in the third quarter of 2023, with production commencing in the second quarter of 2024, according to an announcement by Lingang special area administration in April of last year.</p><p style=\"text-align: left;\">On December 22, 2023, Tesla announced the official launch of the Megafactory project in Shanghai.</p><p style=\"text-align: left;\">The Megapack is a battery that stores energy and supplies it to help stabilize the grid and prevent power outages.</p><p style=\"text-align: left;\">Each Megapack unit can store more than 3 MWh of energy, enough to power 3,600 homes for an hour, according to Tesla&#39;s website.<br/></p><p><br/></p></body></html>","source":"cnevpost_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla's Megapack Plant in Shanghai to Begin Construction in May, Mass Production in Q1 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla's Megapack Plant in Shanghai to Begin Construction in May, Mass Production in Q1 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-17 16:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://cnevpost.com/2024/04/17/tesla-megapack-plant-shanghai-to-begin-construction-in-may-report/><strong>CnEVPost</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Megafactory will be Tesla's first energy storage system factory outside of its US domestic market, with an initial planned annual production capacity of up to 10,000 commercial energy storage ...</p>\n\n<a href=\"https://cnevpost.com/2024/04/17/tesla-megapack-plant-shanghai-to-begin-construction-in-may-report/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://cnevpost.com/2024/04/17/tesla-megapack-plant-shanghai-to-begin-construction-in-may-report/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189337221","content_text":"The Megafactory will be Tesla's first energy storage system factory outside of its US domestic market, with an initial planned annual production capacity of up to 10,000 commercial energy storage batteries.Tesla's Megapack factory in Shanghai is scheduled to start construction in May and begin mass production in the first quarter of 2025, local media outlet The Paper said in a report today, citing sources at Tesla China.Tesla shares gained 0.81% in premarket trading on Wednesday.Tesla's energy storage business has grown at a rapid pace in recent years, with installed capacity reaching 14.7 GWh in 2023, up 125 percent year-on-year, the report noted.The latest timeline reported is a delay from the previously announced plan.Tesla signed an agreement with Shanghai's Lingang authorities on April 9, 2023, to build a new Megafactory in the area, which will be dedicated to the production of the energy storage product Megapack.The Megafactory will be Tesla's first energy storage system factory outside of its US domestic market. It's initially planned to produce up to 10,000 commercial energy storage batteries per year, with nearly 40 GWh of energy storage, and the products will be available to the global market.Construction of the plant was scheduled to begin in the third quarter of 2023, with production commencing in the second quarter of 2024, according to an announcement by Lingang special area administration in April of last year.On December 22, 2023, Tesla announced the official launch of the Megafactory project in Shanghai.The Megapack is a battery that stores energy and supplies it to help stabilize the grid and prevent power outages.Each Megapack unit can store more than 3 MWh of energy, enough to power 3,600 homes for an hour, according to Tesla's website.","news_type":1},"isVote":1,"tweetType":1,"viewCount":67,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":244030409236704,"gmtCreate":1700601796748,"gmtModify":1700601800046,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$&nbsp;</a>","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$&nbsp;</a>","text":"$NVIDIA Corp(NVDA)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/244030409236704","isVote":1,"tweetType":1,"viewCount":248,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":212651636023520,"gmtCreate":1692956743775,"gmtModify":1692956748377,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/212651636023520","repostId":"1133549138","repostType":2,"isVote":1,"tweetType":1,"viewCount":399,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":869457976,"gmtCreate":1632318808095,"gmtModify":1676530751176,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"Hi here is the TA sharing regarding FVRR.From MACD line showing it uptrend. It could be a bullish if the MACD line break the zero reference.Currently the RSI at around 62. It means not too late to buy some share as a start up.If you see from the chart, the first support price range is around 190-200; second support price range is 155-165.And you put in EMA 100 Or 200, it will be shown the share still considered under value from TA basic.Strategy could be taken1)Sell put to get some premium as a start up to buy some share as a start up position. 2) Buy Call ATM -3 since it still at support level.( Do this only you had a strong conviction)","listText":"Hi here is the TA sharing regarding FVRR.From MACD line showing it uptrend. It could be a bullish if the MACD line break the zero reference.Currently the RSI at around 62. It means not too late to buy some share as a start up.If you see from the chart, the first support price range is around 190-200; second support price range is 155-165.And you put in EMA 100 Or 200, it will be shown the share still considered under value from TA basic.Strategy could be taken1)Sell put to get some premium as a start up to buy some share as a start up position. 2) Buy Call ATM -3 since it still at support level.( Do this only you had a strong conviction)","text":"Hi here is the TA sharing regarding FVRR.From MACD line showing it uptrend. It could be a bullish if the MACD line break the zero reference.Currently the RSI at around 62. It means not too late to buy some share as a start up.If you see from the chart, the first support price range is around 190-200; second support price range is 155-165.And you put in EMA 100 Or 200, it will be shown the share still considered under value from TA basic.Strategy could be taken1)Sell put to get some premium as a start up to buy some share as a start up position. 2) Buy Call ATM -3 since it still at support level.( Do this only you had a strong conviction)","images":[{"img":"https://static.tigerbbs.com/528ab93897562a336340ec489a5dc6b8","width":"1366","height":"768"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/869457976","isVote":1,"tweetType":1,"viewCount":294,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":816705172,"gmtCreate":1630532276196,"gmtModify":1676530329368,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>karching","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>karching","text":"$Tiger Brokers(TIGR)$karching","images":[{"img":"https://static.tigerbbs.com/73457e951d9f60b1ed007a5856bfa0c4","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/816705172","isVote":1,"tweetType":1,"viewCount":195,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":805046864,"gmtCreate":1627828467758,"gmtModify":1703496349225,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"Just buy it if you bhad strong conviction on SKLz","listText":"Just buy it if you bhad strong conviction on SKLz","text":"Just buy it if you bhad strong conviction on SKLz","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/805046864","repostId":"1146192957","repostType":4,"repost":{"id":"1146192957","kind":"news","pubTimestamp":1627783930,"share":"https://ttm.financial/m/news/1146192957?lang=&edition=fundamental","pubTime":"2021-08-01 10:12","market":"us","language":"en","title":"Upcoming Earnings Could Bring Back Positive Sentiment for Skillz","url":"https://stock-news.laohu8.com/highlight/detail?id=1146192957","media":"InvestorPlace","summary":"Next week's quarterly numbers could put SKLZ stock back on an upwards trajectory.\n\nSkillz(NYSE:SKLZ)","content":"<blockquote>\n <b>Next week's quarterly numbers could put SKLZ stock back on an upwards trajectory.</b>\n</blockquote>\n<p><b>Skillz</b>(NYSE:<b><u>SKLZ</u></b>) stock has been attempting to recover since May. Some investors dove in because it was a short-squeeze stock. Others bought it for its still-strong growth prospects. But in the past few weeks, SKLZ stock has pulled back once again.</p>\n<p>The latest round of “meme stock madness” has dissipated, and Reddit traders have bailed out of their Skillz shares. Concerns about possible interest rate hikes have also led to bearishness around growth stocks. Both of these factors played a role in knocking SKLZ stock back down to its prior price levels.</p>\n<p>Negative sentiment for Skillz may be on the rise. Yet you still may want to buy it ahead of its next quarterly earnings, which arescheduled to releaseafter the market closes on Aug 3. Just like last quarter, losses could come in higher than expected. But if its sales come in above forecast and management raises 2021 guidance once again, it may be enough to renew investors’ enthusiasm for SKLZ stock.</p>\n<p>Admittedly, its valuation is still a concern. Like other growth stocks, worries about rising rates could give way to multiple contraction. But if you’re confident in its “story,” buying Skillz stock at today’s price may be a solid “buy the dip” situation.</p>\n<p><b>SKLZ Stock and Its Upcoming Earnings Release</b></p>\n<p>As Skillz is not expected to be profitable until it scales up, earnings-per-share (EPS) is not a focus with next week’s earnings release. Instead, investors should look for revenue numbers and any updates to its 2021 guidance.</p>\n<p>Will it meet (or beat) analyst revenue consensus for the quarter ending June 30, 2021? Average revenue estimates for last quarter currently stand at$88.2 million. As<i>InvestorPlace’s</i>Mark Hake discussed July 22, it beat revenue estimates andupped its full-year guidancelast quarter.</p>\n<p>Some may anticipate this happening again. But based on the performance of SKLZ stock over the past month, that’s not the majority opinion.</p>\n<p>In July, shares pulled back more than 30%. Yet this lack of enthusiasm could be a positive for investors bullish on SKLZ stock. Possibly oversold at $14 per share, it could bounce back to $20 per share if its latest results exceed expectations.</p>\n<p>On the other hand, if the company disappoints for the quarter, the stock could get hammered once again. Its valuation is also a risk, so solid results and upgraded guidance may not be enough to keep shares steady, let alone raise them to previous highs.</p>\n<p><b>Caution May Be Needed Even With Strong Results</b></p>\n<p>Obviously, a revenue miss for this richly-priced stock (shares currently trade for 20.4x estimated 2021 sales) would mean big declines ahead. So would any change to the company’s guidance. But that’s not to say it’s all smooth sailing from here if the company beats on sales and positively revises its 2021 forecast.</p>\n<p>Factors that are not company-specific could have a negative impact on the price of SKLZ stock. The first that comes to mind is a possible hike in interest rates. How far could shares sink if multiple contraction continues for growth stocks?</p>\n<p>More mature names in the mobile games space, like<b>Zynga</b>(NASDAQ:<b><u>ZNGA</u></b>), trade at price-to-sales (P/S) ratios in the mid-single digits. Therefore, Skillz’s valuation could fall to high-single digits and still reflect the company’s higher-than-average growth. The issue is that a contraction like this implies a possible 50% in downside from today’s prices.</p>\n<p>Putting it simply, this stock could see a big move higher if its latest earnings beat expectations, but a multiple contraction could have an outsized effect on it as well.</p>\n<p><b>SKLZ Stock May Be Worth the Risk</b></p>\n<p><i>InvestorPlace’s</i>Luke Lango haslaid out the bull casefor SKLZ stock, and his argument is compelling. The company’s mobile gaming platform stands to gain massively if its tournament-based revenue model replaces traditional advertising-based models.</p>\n<p>Next week’s earnings results could remind investors, who have grown more bearish on Skillz in recent weeks, that high growth remains on the menu. This could mean a rapid move back to $20 or more in the short term.</p>\n<p>Granted, its high valuation remains a risk. Shares could fall 50% and still trade at a premium valuation. But if you believe these concerns are overblown and positive sentiment will return, buying SKLZ stock today may be worth it.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Upcoming Earnings Could Bring Back Positive Sentiment for Skillz</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUpcoming Earnings Could Bring Back Positive Sentiment for Skillz\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-01 10:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/07/sklz-stock-upcoming-earnings-could-bring-back-positive-sentiment/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Next week's quarterly numbers could put SKLZ stock back on an upwards trajectory.\n\nSkillz(NYSE:SKLZ) stock has been attempting to recover since May. Some investors dove in because it was a short-...</p>\n\n<a href=\"https://investorplace.com/2021/07/sklz-stock-upcoming-earnings-could-bring-back-positive-sentiment/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SKLZ":"Skillz Inc"},"source_url":"https://investorplace.com/2021/07/sklz-stock-upcoming-earnings-could-bring-back-positive-sentiment/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146192957","content_text":"Next week's quarterly numbers could put SKLZ stock back on an upwards trajectory.\n\nSkillz(NYSE:SKLZ) stock has been attempting to recover since May. Some investors dove in because it was a short-squeeze stock. Others bought it for its still-strong growth prospects. But in the past few weeks, SKLZ stock has pulled back once again.\nThe latest round of “meme stock madness” has dissipated, and Reddit traders have bailed out of their Skillz shares. Concerns about possible interest rate hikes have also led to bearishness around growth stocks. Both of these factors played a role in knocking SKLZ stock back down to its prior price levels.\nNegative sentiment for Skillz may be on the rise. Yet you still may want to buy it ahead of its next quarterly earnings, which arescheduled to releaseafter the market closes on Aug 3. Just like last quarter, losses could come in higher than expected. But if its sales come in above forecast and management raises 2021 guidance once again, it may be enough to renew investors’ enthusiasm for SKLZ stock.\nAdmittedly, its valuation is still a concern. Like other growth stocks, worries about rising rates could give way to multiple contraction. But if you’re confident in its “story,” buying Skillz stock at today’s price may be a solid “buy the dip” situation.\nSKLZ Stock and Its Upcoming Earnings Release\nAs Skillz is not expected to be profitable until it scales up, earnings-per-share (EPS) is not a focus with next week’s earnings release. Instead, investors should look for revenue numbers and any updates to its 2021 guidance.\nWill it meet (or beat) analyst revenue consensus for the quarter ending June 30, 2021? Average revenue estimates for last quarter currently stand at$88.2 million. AsInvestorPlace’sMark Hake discussed July 22, it beat revenue estimates andupped its full-year guidancelast quarter.\nSome may anticipate this happening again. But based on the performance of SKLZ stock over the past month, that’s not the majority opinion.\nIn July, shares pulled back more than 30%. Yet this lack of enthusiasm could be a positive for investors bullish on SKLZ stock. Possibly oversold at $14 per share, it could bounce back to $20 per share if its latest results exceed expectations.\nOn the other hand, if the company disappoints for the quarter, the stock could get hammered once again. Its valuation is also a risk, so solid results and upgraded guidance may not be enough to keep shares steady, let alone raise them to previous highs.\nCaution May Be Needed Even With Strong Results\nObviously, a revenue miss for this richly-priced stock (shares currently trade for 20.4x estimated 2021 sales) would mean big declines ahead. So would any change to the company’s guidance. But that’s not to say it’s all smooth sailing from here if the company beats on sales and positively revises its 2021 forecast.\nFactors that are not company-specific could have a negative impact on the price of SKLZ stock. The first that comes to mind is a possible hike in interest rates. How far could shares sink if multiple contraction continues for growth stocks?\nMore mature names in the mobile games space, likeZynga(NASDAQ:ZNGA), trade at price-to-sales (P/S) ratios in the mid-single digits. Therefore, Skillz’s valuation could fall to high-single digits and still reflect the company’s higher-than-average growth. The issue is that a contraction like this implies a possible 50% in downside from today’s prices.\nPutting it simply, this stock could see a big move higher if its latest earnings beat expectations, but a multiple contraction could have an outsized effect on it as well.\nSKLZ Stock May Be Worth the Risk\nInvestorPlace’sLuke Lango haslaid out the bull casefor SKLZ stock, and his argument is compelling. The company’s mobile gaming platform stands to gain massively if its tournament-based revenue model replaces traditional advertising-based models.\nNext week’s earnings results could remind investors, who have grown more bearish on Skillz in recent weeks, that high growth remains on the menu. This could mean a rapid move back to $20 or more in the short term.\nGranted, its high valuation remains a risk. Shares could fall 50% and still trade at a premium valuation. But if you believe these concerns are overblown and positive sentiment will return, buying SKLZ stock today may be worth it.","news_type":1},"isVote":1,"tweetType":1,"viewCount":214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":175405946,"gmtCreate":1627044984985,"gmtModify":1703483132138,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"This is too risky for investment, this is gambling","listText":"This is too risky for investment, this is gambling","text":"This is too risky for investment, this is gambling","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/175405946","repostId":"1123210107","repostType":4,"repost":{"id":"1123210107","kind":"news","pubTimestamp":1627039688,"share":"https://ttm.financial/m/news/1123210107?lang=&edition=fundamental","pubTime":"2021-07-23 19:28","market":"us","language":"en","title":"Too-Volatile, Too-Disconnected GameStop Stock Will Continue to Burn Shorts","url":"https://stock-news.laohu8.com/highlight/detail?id=1123210107","media":"InvestorPlace","summary":"Playing whack-a-mole with the meme mob isn't a game that GME stock bears can win.\n\nI’ll be the first","content":"<blockquote>\n Playing whack-a-mole with the meme mob isn't a game that GME stock bears can win.\n</blockquote>\n<p>I’ll be the first commentator to admit that video-game retailer<b>GameStop</b>&nbsp;(NYSE:<b><u>GME</u></b>) isn’t making money hand over fist. Yet, this admission doesn’t mean that betting against GME stock is a good idea.</p>\n<p>A few months ago, I evenflipped bullishon GameStop. At that time, I dared adventurous traders to consider a long position.</p>\n<p><img src=\"https://static.tigerbbs.com/0b0e0cafba51a16a83137050c3f2c00b\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Source: Shutterstock / mundissima</p>\n<p>Of course, this isn’t to say that anybody should pour their entire account into GME stock. It’s too volatile for a very large-size position and the stock’s price is too disconnected from the company’s fundamentals.</p>\n<p>So maybe, my stance is best described as resignation rather than optimism. And with that, please join me as I hold my nose and analyze the name that kicked off the meme-stock game.</p>\n<p><b>Looking for the Next GME Stock</b></p>\n<p>Looking back upon a bizarre first half of 2021, it’s interesting to revisit the wild price moves of GME stock.</p>\n<p>Everyone and his uncle wants to find the next GameStop, but there’s really nothing like the original. I mean, the price move in this stock was legendary.</p>\n<p>And, it set up a target for the bulls. When GME stock touched $483 in January, investors’ accounts lit up bright green while short sellers awaited calls from their brokers’ margin desks.</p>\n<p>It was the best of times and the worst of times, depending on which side of the trade you happened to be.</p>\n<p>The short sellers have attempted to fight back, but the GameStop stalwarts seem to have endless energy.</p>\n<p>For an immediate-term target, the bulls can look back to the GME stock price spikes in March and June. Those times, $300 provided a hard resistance point.</p>\n<p>Breaking through that with heavy, sustained volume would set $500 as the level to watch. The bulls almost got there in January — and after all, resistance levels are meant to be taken out.</p>\n<p><b>Short Attention Span</b></p>\n<p>The folks on&nbsp;<b>Reddit</b>&nbsp;and other social media outlets who like to trade and talk stocks sometimes aren’t taken seriously by the financial press.</p>\n<p>That’s a shame, and it’s unfair. Big-money short sellers have pushed stocks in their desired direction for years, so why can’t retail traders band together and take on the institutional “whales”?</p>\n<p>It’s a fascinating debate that involves a David-versus-Goliath battle which continues to this day. But who’s the winner here, really?</p>\n<p>You’d be hard-pressed to consider GameStop, the company at the center of all this, the big winner.</p>\n<p>GameStop’sfirst-quarter financial resultspoint to an operating loss of $40.8 million and adjusted EBITDA of a negative $0.7 million. Clearly, the company is still struggling financially.</p>\n<p>Thus, the retail crowd’s focus is more on the stock than the company itself.</p>\n<p>Surprisingly, though, they’ve kept their attention on GameStop even while focusing on a multitude of other names.</p>\n<p><b>A Rule of Thumb</b></p>\n<p>For not tossing GME stock out like yesterday’s trash, I’ll give the meme-sters respect.</p>\n<p>Furthermore, they haven’t capitulated in the ongoing battle against the short sellers, who undoubtedly control billions of dollars in cash and assets.</p>\n<p>If you’d like to join the grassroots resistance movement against the short sellers, then you’ll want to consider your strategy carefully.</p>\n<p>Small position sizing is rule number one, always. Yet, there’s another guideline to consider.</p>\n<p>Anything above 15% short interest (as measured by short volume ratio) is a good rule of thumb for considering a short squeeze target, in my opinion.</p>\n<p>As of July 21, GME stock’sshort volume ratiowas 24.3%, so this could be a springboard for an epic squeeze.</p>\n<p>With that, the $300 target and even the $500 level could be taken out quickly.</p>\n<p><b>The Bottom Line on GME Stock</b></p>\n<p>We can view this as a battle of the haves versus the have-nots, or simply as a potentially profitable trading opportunity.</p>\n<p>Either way, there could be another major price move coming in GME stock.</p>\n<p>And at the end of the day, there’s no point in judging the meme stock traders. Instead, you might consider joining them and possibly booking some nice profits.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Too-Volatile, Too-Disconnected GameStop Stock Will Continue to Burn Shorts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToo-Volatile, Too-Disconnected GameStop Stock Will Continue to Burn Shorts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-23 19:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/07/short-sellers-will-continue-to-get-burned-with-gme-stock/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Playing whack-a-mole with the meme mob isn't a game that GME stock bears can win.\n\nI’ll be the first commentator to admit that video-game retailerGameStop (NYSE:GME) isn’t making money hand over fist....</p>\n\n<a href=\"https://investorplace.com/2021/07/short-sellers-will-continue-to-get-burned-with-gme-stock/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站"},"source_url":"https://investorplace.com/2021/07/short-sellers-will-continue-to-get-burned-with-gme-stock/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123210107","content_text":"Playing whack-a-mole with the meme mob isn't a game that GME stock bears can win.\n\nI’ll be the first commentator to admit that video-game retailerGameStop (NYSE:GME) isn’t making money hand over fist. Yet, this admission doesn’t mean that betting against GME stock is a good idea.\nA few months ago, I evenflipped bullishon GameStop. At that time, I dared adventurous traders to consider a long position.\nSource: Shutterstock / mundissima\nOf course, this isn’t to say that anybody should pour their entire account into GME stock. It’s too volatile for a very large-size position and the stock’s price is too disconnected from the company’s fundamentals.\nSo maybe, my stance is best described as resignation rather than optimism. And with that, please join me as I hold my nose and analyze the name that kicked off the meme-stock game.\nLooking for the Next GME Stock\nLooking back upon a bizarre first half of 2021, it’s interesting to revisit the wild price moves of GME stock.\nEveryone and his uncle wants to find the next GameStop, but there’s really nothing like the original. I mean, the price move in this stock was legendary.\nAnd, it set up a target for the bulls. When GME stock touched $483 in January, investors’ accounts lit up bright green while short sellers awaited calls from their brokers’ margin desks.\nIt was the best of times and the worst of times, depending on which side of the trade you happened to be.\nThe short sellers have attempted to fight back, but the GameStop stalwarts seem to have endless energy.\nFor an immediate-term target, the bulls can look back to the GME stock price spikes in March and June. Those times, $300 provided a hard resistance point.\nBreaking through that with heavy, sustained volume would set $500 as the level to watch. The bulls almost got there in January — and after all, resistance levels are meant to be taken out.\nShort Attention Span\nThe folks on Reddit and other social media outlets who like to trade and talk stocks sometimes aren’t taken seriously by the financial press.\nThat’s a shame, and it’s unfair. Big-money short sellers have pushed stocks in their desired direction for years, so why can’t retail traders band together and take on the institutional “whales”?\nIt’s a fascinating debate that involves a David-versus-Goliath battle which continues to this day. But who’s the winner here, really?\nYou’d be hard-pressed to consider GameStop, the company at the center of all this, the big winner.\nGameStop’sfirst-quarter financial resultspoint to an operating loss of $40.8 million and adjusted EBITDA of a negative $0.7 million. Clearly, the company is still struggling financially.\nThus, the retail crowd’s focus is more on the stock than the company itself.\nSurprisingly, though, they’ve kept their attention on GameStop even while focusing on a multitude of other names.\nA Rule of Thumb\nFor not tossing GME stock out like yesterday’s trash, I’ll give the meme-sters respect.\nFurthermore, they haven’t capitulated in the ongoing battle against the short sellers, who undoubtedly control billions of dollars in cash and assets.\nIf you’d like to join the grassroots resistance movement against the short sellers, then you’ll want to consider your strategy carefully.\nSmall position sizing is rule number one, always. Yet, there’s another guideline to consider.\nAnything above 15% short interest (as measured by short volume ratio) is a good rule of thumb for considering a short squeeze target, in my opinion.\nAs of July 21, GME stock’sshort volume ratiowas 24.3%, so this could be a springboard for an epic squeeze.\nWith that, the $300 target and even the $500 level could be taken out quickly.\nThe Bottom Line on GME Stock\nWe can view this as a battle of the haves versus the have-nots, or simply as a potentially profitable trading opportunity.\nEither way, there could be another major price move coming in GME stock.\nAnd at the end of the day, there’s no point in judging the meme stock traders. Instead, you might consider joining them and possibly booking some nice profits.","news_type":1},"isVote":1,"tweetType":1,"viewCount":405,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":175406147,"gmtCreate":1627044907589,"gmtModify":1703483128846,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"China always learn when they copy others country and they will turn the technology into a new way of transform.","listText":"China always learn when they copy others country and they will turn the technology into a new way of transform.","text":"China always learn when they copy others country and they will turn the technology into a new way of transform.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/175406147","repostId":"2153092983","repostType":4,"repost":{"id":"2153092983","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1627043880,"share":"https://ttm.financial/m/news/2153092983?lang=&edition=fundamental","pubTime":"2021-07-23 20:38","market":"hk","language":"en","title":"Nio stock falls after shareholders file to sell off their stakes","url":"https://stock-news.laohu8.com/highlight/detail?id=2153092983","media":"Dow Jones","summary":"Share of Nio Inc. $$ shed 3.52% in premarket trading Friday, after the China-based electric vehicle maker disclosed the offering of 1.68 million shares by selling stockholders.In and S-1 filing with the Securities and Exchange Commission late Thursday, Quasar Energy Partners LLC, Philipp Brothers Fertilizer LLC and Little Brothers LLC are selling off their entire stakes in Nio, totaling 1,682,267 shares, representing 0.4% of the shares outstanding and valued at $77.5 million at Thursday's closin","content":"<p>Share of Nio Inc. <a href=\"https://laohu8.com/S/NIO\">$(NIO)$</a> shed 3.52% in premarket trading Friday, after the China-based electric vehicle maker disclosed the offering of 1.68 million shares by selling stockholders. </p>\n<p>In and S-1 filing with the Securities and Exchange Commission late Thursday, Quasar Energy Partners LLC, Philipp Brothers Fertilizer LLC and Little Brothers LLC are selling off their entire stakes in Nio, totaling 1,682,267 shares, representing 0.4% of the shares outstanding and valued at $77.5 million at Thursday's closing price of $46.07. </p>\n<p>The company said it will not receive any proceeds from the offering. </p>\n<p>The stock has lost 5.5% year to date, while shares of U.S.-based EV leader Tesla Inc. <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a> have declined 8.0%, the <a href=\"https://laohu8.com/S/IHPXF\">iShares MSCI</a> China ETF <a href=\"https://laohu8.com/S/MCHI\">$(MCHI)$</a> has slipped 4.3% and the S&amp;P 500 has gained 16.3%.</p>\n<p><img src=\"https://static.tigerbbs.com/ee090a0f70c06269be38978083eb233f\" tg-width=\"903\" tg-height=\"542\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nio stock falls after shareholders file to sell off their stakes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNio stock falls after shareholders file to sell off their stakes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-07-23 20:38</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Share of Nio Inc. <a href=\"https://laohu8.com/S/NIO\">$(NIO)$</a> shed 3.52% in premarket trading Friday, after the China-based electric vehicle maker disclosed the offering of 1.68 million shares by selling stockholders. </p>\n<p>In and S-1 filing with the Securities and Exchange Commission late Thursday, Quasar Energy Partners LLC, Philipp Brothers Fertilizer LLC and Little Brothers LLC are selling off their entire stakes in Nio, totaling 1,682,267 shares, representing 0.4% of the shares outstanding and valued at $77.5 million at Thursday's closing price of $46.07. </p>\n<p>The company said it will not receive any proceeds from the offering. </p>\n<p>The stock has lost 5.5% year to date, while shares of U.S.-based EV leader Tesla Inc. <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a> have declined 8.0%, the <a href=\"https://laohu8.com/S/IHPXF\">iShares MSCI</a> China ETF <a href=\"https://laohu8.com/S/MCHI\">$(MCHI)$</a> has slipped 4.3% and the S&amp;P 500 has gained 16.3%.</p>\n<p><img src=\"https://static.tigerbbs.com/ee090a0f70c06269be38978083eb233f\" tg-width=\"903\" tg-height=\"542\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","MCHI":"中国ETF-iShares MSCI","NIO":"蔚来"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153092983","content_text":"Share of Nio Inc. $(NIO)$ shed 3.52% in premarket trading Friday, after the China-based electric vehicle maker disclosed the offering of 1.68 million shares by selling stockholders. \nIn and S-1 filing with the Securities and Exchange Commission late Thursday, Quasar Energy Partners LLC, Philipp Brothers Fertilizer LLC and Little Brothers LLC are selling off their entire stakes in Nio, totaling 1,682,267 shares, representing 0.4% of the shares outstanding and valued at $77.5 million at Thursday's closing price of $46.07. \nThe company said it will not receive any proceeds from the offering. \nThe stock has lost 5.5% year to date, while shares of U.S.-based EV leader Tesla Inc. $(TSLA)$ have declined 8.0%, the iShares MSCI China ETF $(MCHI)$ has slipped 4.3% and the S&P 500 has gained 16.3%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":229,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":175409758,"gmtCreate":1627044794374,"gmtModify":1703483124564,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"China is looking in a long term view. Fabulous","listText":"China is looking in a long term view. Fabulous","text":"China is looking in a long term view. Fabulous","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/175409758","repostId":"1193325824","repostType":4,"repost":{"id":"1193325824","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1627040657,"share":"https://ttm.financial/m/news/1193325824?lang=&edition=fundamental","pubTime":"2021-07-23 19:44","market":"us","language":"en","title":"Toplines Before US Market Open on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1193325824","media":"Tiger Newspress","summary":"U.S. equity futures climbed Friday.\nChinese education companies plunged n U.S. pre-market trading, o","content":"<ul>\n <li>U.S. equity futures climbed Friday.</li>\n <li>Chinese education companies&nbsp;plunged&nbsp;n U.S. pre-market trading,&nbsp;on fears of a Chinese government crackdown on the for-profit education sector.</li>\n <li>Twitter jumps in U.S. pre-market trading.</li>\n <li>Treasury yields rise</li>\n</ul>\n<p>(July 23)&nbsp;U.S. equity futures climbed Friday amid earnings optimism that’s pushing global stocks back toward all-time highs despite mixed economic data and concern about the spread of coronavirus variants.</p>\n<p>At 7:48 a.m. ET, Dow E-minis were up 162 points, or 0.47%, S&amp;P 500 E-minis were up 18&nbsp;points, or 0.41% and Nasdaq 100 E-minis rose 47 points, or 0.31%.</p>\n<p><img src=\"https://static.tigerbbs.com/eed58784c2a140331aa337f0cd7409a9\" tg-width=\"1242\" tg-height=\"493\" width=\"100%\" height=\"auto\">On Friday, investors may react to services and manufacturing data that is likely to underscore the economy's strength.<b>Markit's preliminary U.S. Manufacturing PMI for</b>July is expected to check in at 62.0, marginally lower than June's reading. The Services index is forecasted at 64.5, also nominally lower than June.</p>\n<p>Strong earnings have helped the market heal fromMonday's pandemic-inspired meltdown, with investors looking at the fundamentals rather than surging coronavirus numbers.</p>\n<p>Among individual stocks, Snap leapt 16% in premarket trading on revenue that more than doubled in the second quarter and thefastest user growth in four years.American Expressgained over 4% on forecast-beating earnings and revenue as spending accelerated in the three months through June.</p>\n<p><img src=\"https://static.tigerbbs.com/19afa7f0f2c9a2e8326d550c712f1aeb\" tg-width=\"904\" tg-height=\"547\" width=\"100%\" height=\"auto\"></p>\n<p>Twitter&nbsp;shares rose over 4% in premarket trading after thesocial-media companyreported a 74% increase in revenue in the second quarter compared with a year before.Intel’sstock fell 2.5% after Chief Executive Pat Gelsinger said he sees theglobal semiconductor shortagepotentially stretching into 2023.</p>\n<p><img src=\"https://static.tigerbbs.com/44f865e1f4a5a10b19a7af3f725ba2ec\" tg-width=\"903\" tg-height=\"542\" width=\"100%\" height=\"auto\"></p>\n<p>Of the roughly 110 companies in the S&amp;P 500 that had posted results through Thursday for the second quarter, 85% topped analysts’ profit forecasts, according to FactSet.</p>\n<p>TAL Education Groupshares, listed in New York, plunged 58% premarket on fears of a Chinese government crackdown on the for-profit education sector, and after-school tutoring in particular. An unverified document, circulating among investors and seen by The Wall Street Journal, appeared to be an official communication detailing tougher guidelines. Analysts at Jefferies say investors have grown worried about the outlook for after-school tutoring, and are concerned it may have to be done on a nonprofit basis.</p>\n<p>Other Chinese education companies also took a hit. American depositary receipts of Beijing-based17 Education &amp; Technology Group&nbsp;slumped 40% premarket.</p>\n<p><img src=\"https://static.tigerbbs.com/f4153b474a23280e6cce5a881a3647a4\" tg-width=\"376\" tg-height=\"251\" width=\"100%\" height=\"auto\"></p>\n<p>Survey data on the manufacturing and service sectors, due at 9:45 a.m. ET, will offer fresh cues on theoutlook for the economy. Economists say the U.S.’s growth spurt likely peaked in the spring, but still expect a strong expansion to continue into 2022.</p>\n<p>In the bond market, theyield on 10-year Treasury notesticked up to 1.297% from 1.264% Thursday. Yields move in the opposite direction to bond prices.</p>\n<p>“This was always going to be a difficult moment when we move from that [economic] rebound to normal rates of growth,” said Paul Jackson, head of asset allocation research at Invesco. “So I suspect the markets will continue to trend higher, but we will get these little pockets of volatility.</p>\n<p>Oil prices wavered between small gains and losses. Futures for West Texas Intermediate, the main grade of U.S. crude, were roughly flat at $71.87 a barrel, putting themon track for a muted weekly gain.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-07-23 19:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>U.S. equity futures climbed Friday.</li>\n <li>Chinese education companies&nbsp;plunged&nbsp;n U.S. pre-market trading,&nbsp;on fears of a Chinese government crackdown on the for-profit education sector.</li>\n <li>Twitter jumps in U.S. pre-market trading.</li>\n <li>Treasury yields rise</li>\n</ul>\n<p>(July 23)&nbsp;U.S. equity futures climbed Friday amid earnings optimism that’s pushing global stocks back toward all-time highs despite mixed economic data and concern about the spread of coronavirus variants.</p>\n<p>At 7:48 a.m. ET, Dow E-minis were up 162 points, or 0.47%, S&amp;P 500 E-minis were up 18&nbsp;points, or 0.41% and Nasdaq 100 E-minis rose 47 points, or 0.31%.</p>\n<p><img src=\"https://static.tigerbbs.com/eed58784c2a140331aa337f0cd7409a9\" tg-width=\"1242\" tg-height=\"493\" width=\"100%\" height=\"auto\">On Friday, investors may react to services and manufacturing data that is likely to underscore the economy's strength.<b>Markit's preliminary U.S. Manufacturing PMI for</b>July is expected to check in at 62.0, marginally lower than June's reading. The Services index is forecasted at 64.5, also nominally lower than June.</p>\n<p>Strong earnings have helped the market heal fromMonday's pandemic-inspired meltdown, with investors looking at the fundamentals rather than surging coronavirus numbers.</p>\n<p>Among individual stocks, Snap leapt 16% in premarket trading on revenue that more than doubled in the second quarter and thefastest user growth in four years.American Expressgained over 4% on forecast-beating earnings and revenue as spending accelerated in the three months through June.</p>\n<p><img src=\"https://static.tigerbbs.com/19afa7f0f2c9a2e8326d550c712f1aeb\" tg-width=\"904\" tg-height=\"547\" width=\"100%\" height=\"auto\"></p>\n<p>Twitter&nbsp;shares rose over 4% in premarket trading after thesocial-media companyreported a 74% increase in revenue in the second quarter compared with a year before.Intel’sstock fell 2.5% after Chief Executive Pat Gelsinger said he sees theglobal semiconductor shortagepotentially stretching into 2023.</p>\n<p><img src=\"https://static.tigerbbs.com/44f865e1f4a5a10b19a7af3f725ba2ec\" tg-width=\"903\" tg-height=\"542\" width=\"100%\" height=\"auto\"></p>\n<p>Of the roughly 110 companies in the S&amp;P 500 that had posted results through Thursday for the second quarter, 85% topped analysts’ profit forecasts, according to FactSet.</p>\n<p>TAL Education Groupshares, listed in New York, plunged 58% premarket on fears of a Chinese government crackdown on the for-profit education sector, and after-school tutoring in particular. An unverified document, circulating among investors and seen by The Wall Street Journal, appeared to be an official communication detailing tougher guidelines. Analysts at Jefferies say investors have grown worried about the outlook for after-school tutoring, and are concerned it may have to be done on a nonprofit basis.</p>\n<p>Other Chinese education companies also took a hit. American depositary receipts of Beijing-based17 Education &amp; Technology Group&nbsp;slumped 40% premarket.</p>\n<p><img src=\"https://static.tigerbbs.com/f4153b474a23280e6cce5a881a3647a4\" tg-width=\"376\" tg-height=\"251\" width=\"100%\" height=\"auto\"></p>\n<p>Survey data on the manufacturing and service sectors, due at 9:45 a.m. ET, will offer fresh cues on theoutlook for the economy. Economists say the U.S.’s growth spurt likely peaked in the spring, but still expect a strong expansion to continue into 2022.</p>\n<p>In the bond market, theyield on 10-year Treasury notesticked up to 1.297% from 1.264% Thursday. Yields move in the opposite direction to bond prices.</p>\n<p>“This was always going to be a difficult moment when we move from that [economic] rebound to normal rates of growth,” said Paul Jackson, head of asset allocation research at Invesco. “So I suspect the markets will continue to trend higher, but we will get these little pockets of volatility.</p>\n<p>Oil prices wavered between small gains and losses. Futures for West Texas Intermediate, the main grade of U.S. crude, were roughly flat at $71.87 a barrel, putting themon track for a muted weekly gain.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite","SPY":"标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1193325824","content_text":"U.S. equity futures climbed Friday.\nChinese education companies plunged n U.S. pre-market trading, on fears of a Chinese government crackdown on the for-profit education sector.\nTwitter jumps in U.S. pre-market trading.\nTreasury yields rise\n\n(July 23) U.S. equity futures climbed Friday amid earnings optimism that’s pushing global stocks back toward all-time highs despite mixed economic data and concern about the spread of coronavirus variants.\nAt 7:48 a.m. ET, Dow E-minis were up 162 points, or 0.47%, S&P 500 E-minis were up 18 points, or 0.41% and Nasdaq 100 E-minis rose 47 points, or 0.31%.\nOn Friday, investors may react to services and manufacturing data that is likely to underscore the economy's strength.Markit's preliminary U.S. Manufacturing PMI forJuly is expected to check in at 62.0, marginally lower than June's reading. The Services index is forecasted at 64.5, also nominally lower than June.\nStrong earnings have helped the market heal fromMonday's pandemic-inspired meltdown, with investors looking at the fundamentals rather than surging coronavirus numbers.\nAmong individual stocks, Snap leapt 16% in premarket trading on revenue that more than doubled in the second quarter and thefastest user growth in four years.American Expressgained over 4% on forecast-beating earnings and revenue as spending accelerated in the three months through June.\n\nTwitter shares rose over 4% in premarket trading after thesocial-media companyreported a 74% increase in revenue in the second quarter compared with a year before.Intel’sstock fell 2.5% after Chief Executive Pat Gelsinger said he sees theglobal semiconductor shortagepotentially stretching into 2023.\n\nOf the roughly 110 companies in the S&P 500 that had posted results through Thursday for the second quarter, 85% topped analysts’ profit forecasts, according to FactSet.\nTAL Education Groupshares, listed in New York, plunged 58% premarket on fears of a Chinese government crackdown on the for-profit education sector, and after-school tutoring in particular. An unverified document, circulating among investors and seen by The Wall Street Journal, appeared to be an official communication detailing tougher guidelines. Analysts at Jefferies say investors have grown worried about the outlook for after-school tutoring, and are concerned it may have to be done on a nonprofit basis.\nOther Chinese education companies also took a hit. American depositary receipts of Beijing-based17 Education & Technology Group slumped 40% premarket.\n\nSurvey data on the manufacturing and service sectors, due at 9:45 a.m. ET, will offer fresh cues on theoutlook for the economy. Economists say the U.S.’s growth spurt likely peaked in the spring, but still expect a strong expansion to continue into 2022.\nIn the bond market, theyield on 10-year Treasury notesticked up to 1.297% from 1.264% Thursday. Yields move in the opposite direction to bond prices.\n“This was always going to be a difficult moment when we move from that [economic] rebound to normal rates of growth,” said Paul Jackson, head of asset allocation research at Invesco. “So I suspect the markets will continue to trend higher, but we will get these little pockets of volatility.\nOil prices wavered between small gains and losses. Futures for West Texas Intermediate, the main grade of U.S. crude, were roughly flat at $71.87 a barrel, putting themon track for a muted weekly gain.","news_type":1},"isVote":1,"tweetType":1,"viewCount":140,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176690118,"gmtCreate":1626878403634,"gmtModify":1703479855018,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"Fabulous","listText":"Fabulous","text":"Fabulous","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/176690118","repostId":"1107219983","repostType":4,"repost":{"id":"1107219983","kind":"news","pubTimestamp":1626858926,"share":"https://ttm.financial/m/news/1107219983?lang=&edition=fundamental","pubTime":"2021-07-21 17:15","market":"us","language":"en","title":"Here Is The One-Word Reason Why JPMorgan Just Raised Its S&P Target To 4,600","url":"https://stock-news.laohu8.com/highlight/detail?id=1107219983","media":"zerohedge","summary":"Mid-cycle?Late-cycle? Nope: according to the latest note published overnight from JPMorgan head glob","content":"<p>Mid-cycle?Late-cycle? Nope: according to the latest note published overnight from JPMorgan head global equity strategist Dubravko Lakos-Bujas, \"even though equity leadership and bonds are trading as if the global economy is entering late cycle,<b>our research suggests the recovery is still in early-cycle</b>and gradually transitioning towards mid-cycle.\" And echoing his JPM colleague and fellow Croat, Marko Kolanovic, who yesterdayadvised clients to stop freaking out about the delta variant(advise which markets are taking to heart today), Dubravko writes that the largest commercial bank remains \"constructive on equities and see the latest round of growth and slowdown fears premature and overblown.\"</p>\n<p><img src=\"https://static.tigerbbs.com/52b0923c42b8b316b85e56a776fa3337\" tg-width=\"1132\" tg-height=\"1215\" width=\"100%\" height=\"auto\">Elaborating on why he is sanguine about the current Delta case breakout, Lakos-Bujas writes that \"we remain of the view that this latest wave will not derail the broader reopening process. While cases have gone up, deaths / hospitalizations remain low and stable due to broadening vaccination rollout and self-immunity from prior waves.\"</p>\n<p><img src=\"https://static.tigerbbs.com/d396ca943f750f3a3bcb38e01a53cbdf\" tg-width=\"772\" tg-height=\"546\" width=\"100%\" height=\"auto\">The strategist then argues that \"reopening of the economy is not an event but rather a process, which in our opinion is still not priced-in, and especially not now given recent market moves. For instance, an increasing number of reopening stocks are now down 30-50% from 1Q21 highs (i.e. travel, cruise lines, oil) and some have reversed back to last year June levels when COVID-19 uncertainty and economic setup were vastly worse than today.\"</p>\n<p>Given the above, JPM sees \"increasingly compelling\" risk/reward for the reopening theme, which can be expressed through Consumer Recovery (JPAMCONR &lt;Index&gt;), Domestic Recovery (JPAMCRDB &lt;Index&gt;) and International Recovery (JPAMCRIB &lt;Index&gt;) baskets, see Fig 1.\" Additionally, JPm argues that global mobility remains nascent and its normalization will continue to release pent-up demand, while tight inventories and new orders bode positively for global growth.</p>\n<p><img src=\"https://static.tigerbbs.com/dc9c52172685e208ffe19abe53233205\" tg-width=\"958\" tg-height=\"959\" width=\"100%\" height=\"auto\">Combining all this bullishness,<b>the JPM equity strategist is revising his EPS estimates higher by an additional $5 to $205 for 2021 and raises the bank's long-held 2021 year-end price target of 4,400 to 4,600, due to the following considerations:</b></p>\n<blockquote>\n At a thematic/sector level, the risk/reward for reopening stocks has improved significantly with the recent pullback creating many unusually attractive opportunities for investors to re-enter various parts of the cyclical cohort. Consumer Discretionary (i.e. Retail, Travel &amp; Leisure), Semis, Banks and Energy are strong buys at current levels. For instance,\n <b>large-cap Energy is now trading at a ~10% FCF yield and a &gt;8% FCF/EV yield at $70 Brent in 2022, with leverage that is &lt;1x</b>. The sector has increasing potential for a sharp short squeeze and move higher, given its extreme disconnect from oil fundamentals (i.e. widest in 30+ years, Figure 10). In addition, our Semiconductor research argues that we are only 30-40% of the way into&nbsp; the current semiconductor upcycle and expect strong Y/Y growth into next year with positive EPS revisions for the next 3-4 quarters. Supply will likely remain tight into 2022, while demand remains strong (20-40% above companies’ ability to supply), thus this supply demand imbalance will persist through 2021. Although customers are responding to tight supply with higher than needed orders, ongoing supply tightness is limiting fulfillment. In fact, JPM expects channel and customer inventories to decline Q/Q again in the just completed June quarter.\n</blockquote>\n<p>Looking at the fundamentals, JPM predicts that S&amp;P 500 gains should also be supported by strong earnings growth and capital return until 2023,<b>and is why JPM is adjusting its above consensus S&amp;P 500 EPS by another $5 for 2022 to $230 (consensus $214) and 2023 to $250 (consensus $233).</b></p>\n<blockquote>\n This revision is largely due to global reopening which is delayed and bound to release further pent-up demand, inventory replenishment, rising profitability for Energy companies, and ongoing policy actions (childcare, infrastructure, etc). We expect cumulative revenue growth of ~30% by 2023 relative to pre-COVID (FY 2019), ~150bp net income margin expansion to a record high at over 13%, and gross buybacks nearing an annual pace of ~$1t during this period.\n</blockquote>\n<p>While all sectors are expected to contribute to earnings growth, JPM expects reflation sensitive sectors (Commodities, Financials, Industrials) and Consumer to do the heaviest lifting in the coming quarters in terms of beats and revisions.</p>\n<p>Putting it all together, Lakos-Bujas says that \"<b>considering this outlook for earnings and shareholder return, we are raising our Price Target to 4,600 for year-end 2021.\"</b></p>\n<p>But while any first year strategist can goalseek a fundamentally bullish narrative and chart it, as JPM has done below...</p>\n<p><img src=\"https://static.tigerbbs.com/41e87174356d968c69893caff66745e0\" tg-width=\"1072\" tg-height=\"1304\" width=\"100%\" height=\"auto\">... there is a very specific reason behind JPM's bullish reversal:<b>the coming surge in buybacks which will result in a boom in shareholder returns,</b>or as Dubravko notes, \"corporates have already increased gross buybacks from pandemic era low of $525b (trailing twelve months as of 1Q21) to an annualized run rate of ~$775b YTD and should surpass previous record of ~$850b (as of 1Q19).\"</p>\n<p><img src=\"https://static.tigerbbs.com/3b09d295af263e87277eaffbda47bb7c\" tg-width=\"1076\" tg-height=\"435\" width=\"100%\" height=\"auto\">In practical terms, JPM expects a sharp drop in the S&amp;P's share count in the next 24 months as the buyback-facilitated slow-motion LBO continues.</p>\n<p><img src=\"https://static.tigerbbs.com/ae94ad29f188e3aac5cdf92b9df65fc3\" tg-width=\"1048\" tg-height=\"396\" width=\"100%\" height=\"auto\">Some more details below on the one biggest catalyst behind JPM's SPX price target hike:</p>\n<blockquote>\n <b>Expecting a boom in shareholder return led by buybacks.</b>Buybacks are reemerging as a key theme with net buyback activity significantly improving this year after bottoming in 2Q20. Corporate buyback announcements, typically a leading indicator of buyback execution activity and corporate confidence, have already well-exceeded 2020 levels ($431B YTD vs. $307B 2020, see Figure 25). In fact,\n <b>the rebound in announcement activity is similar to the surge post-TCJA (see Figure 23) which is tracking towards and it is likely to easily surpass ~$650B by year-end and likely to see rolling 12-month announcements surpass prior record level of ~$1T.</b>Historically, buyback announcements have been concentrated within Technology and Financials. However, YTD we are seeing strong announcement activity from Communications as well (driven by GOOGL ~$50B in Apr). As a reminder, ~$90B of Tech’s $133B in announcements YTD is supported by AAPL and ~$25B of Financials' ~$92B is supported by BAC.\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/774d4e9c2550b27c62d10733947c8de4\" tg-width=\"1077\" tg-height=\"384\" width=\"100%\" height=\"auto\">With the June 30th lifting of pandemic era restriction on US Banks,<b>we could see some further pick-up in buyback announcements.</b>Dry powder (i.e. announced repurchase programs not yet executed) levels have been recovering to pre-pandemic levels (~$658B, see Figure 27) as executions have been relatively slower to rebound but should show a material sequential growth in the coming quarters. With record profit margins (~13% in 2022 vs ~11.5% in 2019), bloated cash levels of $2.0T ex-financials (vs. $1.6T pre- COVID), and lower high grade debt yields (JULI at 2.6% now, vs 3.3% prepandemic),<b>we are expecting a boom in buyback activity over the next year.</b>Gross buybacks should surpass the prior executed high of $850b.</p>\n<p><img src=\"https://static.tigerbbs.com/053354e7e2fc9ea74585b437e0d77f78\" tg-width=\"1076\" tg-height=\"415\" width=\"100%\" height=\"auto\">In summary,<i>assuming $875b in buybacks and dividend income of $575 over the next year,</i>JPM calculates that<b>the expected shareholder yield is 3.9%.</b>This, as Dubravko concludes, \"is a significant cross-asset valuation support for equities at a time when 10yr US bonds are yielding 1.2% and $13 trillion of global debt has a negative yield.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here Is The One-Word Reason Why JPMorgan Just Raised Its S&P Target To 4,600</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere Is The One-Word Reason Why JPMorgan Just Raised Its S&P Target To 4,600\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-21 17:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/here-one-word-reason-why-jpmorgan-just-raised-its-sp-target-4600><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Mid-cycle?Late-cycle? Nope: according to the latest note published overnight from JPMorgan head global equity strategist Dubravko Lakos-Bujas, \"even though equity leadership and bonds are trading as ...</p>\n\n<a href=\"https://www.zerohedge.com/markets/here-one-word-reason-why-jpmorgan-just-raised-its-sp-target-4600\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","SPY":"标普500ETF"},"source_url":"https://www.zerohedge.com/markets/here-one-word-reason-why-jpmorgan-just-raised-its-sp-target-4600","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107219983","content_text":"Mid-cycle?Late-cycle? Nope: according to the latest note published overnight from JPMorgan head global equity strategist Dubravko Lakos-Bujas, \"even though equity leadership and bonds are trading as if the global economy is entering late cycle,our research suggests the recovery is still in early-cycleand gradually transitioning towards mid-cycle.\" And echoing his JPM colleague and fellow Croat, Marko Kolanovic, who yesterdayadvised clients to stop freaking out about the delta variant(advise which markets are taking to heart today), Dubravko writes that the largest commercial bank remains \"constructive on equities and see the latest round of growth and slowdown fears premature and overblown.\"\nElaborating on why he is sanguine about the current Delta case breakout, Lakos-Bujas writes that \"we remain of the view that this latest wave will not derail the broader reopening process. While cases have gone up, deaths / hospitalizations remain low and stable due to broadening vaccination rollout and self-immunity from prior waves.\"\nThe strategist then argues that \"reopening of the economy is not an event but rather a process, which in our opinion is still not priced-in, and especially not now given recent market moves. For instance, an increasing number of reopening stocks are now down 30-50% from 1Q21 highs (i.e. travel, cruise lines, oil) and some have reversed back to last year June levels when COVID-19 uncertainty and economic setup were vastly worse than today.\"\nGiven the above, JPM sees \"increasingly compelling\" risk/reward for the reopening theme, which can be expressed through Consumer Recovery (JPAMCONR <Index>), Domestic Recovery (JPAMCRDB <Index>) and International Recovery (JPAMCRIB <Index>) baskets, see Fig 1.\" Additionally, JPm argues that global mobility remains nascent and its normalization will continue to release pent-up demand, while tight inventories and new orders bode positively for global growth.\nCombining all this bullishness,the JPM equity strategist is revising his EPS estimates higher by an additional $5 to $205 for 2021 and raises the bank's long-held 2021 year-end price target of 4,400 to 4,600, due to the following considerations:\n\n At a thematic/sector level, the risk/reward for reopening stocks has improved significantly with the recent pullback creating many unusually attractive opportunities for investors to re-enter various parts of the cyclical cohort. Consumer Discretionary (i.e. Retail, Travel & Leisure), Semis, Banks and Energy are strong buys at current levels. For instance,\n large-cap Energy is now trading at a ~10% FCF yield and a >8% FCF/EV yield at $70 Brent in 2022, with leverage that is <1x. The sector has increasing potential for a sharp short squeeze and move higher, given its extreme disconnect from oil fundamentals (i.e. widest in 30+ years, Figure 10). In addition, our Semiconductor research argues that we are only 30-40% of the way into  the current semiconductor upcycle and expect strong Y/Y growth into next year with positive EPS revisions for the next 3-4 quarters. Supply will likely remain tight into 2022, while demand remains strong (20-40% above companies’ ability to supply), thus this supply demand imbalance will persist through 2021. Although customers are responding to tight supply with higher than needed orders, ongoing supply tightness is limiting fulfillment. In fact, JPM expects channel and customer inventories to decline Q/Q again in the just completed June quarter.\n\nLooking at the fundamentals, JPM predicts that S&P 500 gains should also be supported by strong earnings growth and capital return until 2023,and is why JPM is adjusting its above consensus S&P 500 EPS by another $5 for 2022 to $230 (consensus $214) and 2023 to $250 (consensus $233).\n\n This revision is largely due to global reopening which is delayed and bound to release further pent-up demand, inventory replenishment, rising profitability for Energy companies, and ongoing policy actions (childcare, infrastructure, etc). We expect cumulative revenue growth of ~30% by 2023 relative to pre-COVID (FY 2019), ~150bp net income margin expansion to a record high at over 13%, and gross buybacks nearing an annual pace of ~$1t during this period.\n\nWhile all sectors are expected to contribute to earnings growth, JPM expects reflation sensitive sectors (Commodities, Financials, Industrials) and Consumer to do the heaviest lifting in the coming quarters in terms of beats and revisions.\nPutting it all together, Lakos-Bujas says that \"considering this outlook for earnings and shareholder return, we are raising our Price Target to 4,600 for year-end 2021.\"\nBut while any first year strategist can goalseek a fundamentally bullish narrative and chart it, as JPM has done below...\n... there is a very specific reason behind JPM's bullish reversal:the coming surge in buybacks which will result in a boom in shareholder returns,or as Dubravko notes, \"corporates have already increased gross buybacks from pandemic era low of $525b (trailing twelve months as of 1Q21) to an annualized run rate of ~$775b YTD and should surpass previous record of ~$850b (as of 1Q19).\"\nIn practical terms, JPM expects a sharp drop in the S&P's share count in the next 24 months as the buyback-facilitated slow-motion LBO continues.\nSome more details below on the one biggest catalyst behind JPM's SPX price target hike:\n\nExpecting a boom in shareholder return led by buybacks.Buybacks are reemerging as a key theme with net buyback activity significantly improving this year after bottoming in 2Q20. Corporate buyback announcements, typically a leading indicator of buyback execution activity and corporate confidence, have already well-exceeded 2020 levels ($431B YTD vs. $307B 2020, see Figure 25). In fact,\n the rebound in announcement activity is similar to the surge post-TCJA (see Figure 23) which is tracking towards and it is likely to easily surpass ~$650B by year-end and likely to see rolling 12-month announcements surpass prior record level of ~$1T.Historically, buyback announcements have been concentrated within Technology and Financials. However, YTD we are seeing strong announcement activity from Communications as well (driven by GOOGL ~$50B in Apr). As a reminder, ~$90B of Tech’s $133B in announcements YTD is supported by AAPL and ~$25B of Financials' ~$92B is supported by BAC.\n\nWith the June 30th lifting of pandemic era restriction on US Banks,we could see some further pick-up in buyback announcements.Dry powder (i.e. announced repurchase programs not yet executed) levels have been recovering to pre-pandemic levels (~$658B, see Figure 27) as executions have been relatively slower to rebound but should show a material sequential growth in the coming quarters. With record profit margins (~13% in 2022 vs ~11.5% in 2019), bloated cash levels of $2.0T ex-financials (vs. $1.6T pre- COVID), and lower high grade debt yields (JULI at 2.6% now, vs 3.3% prepandemic),we are expecting a boom in buyback activity over the next year.Gross buybacks should surpass the prior executed high of $850b.\nIn summary,assuming $875b in buybacks and dividend income of $575 over the next year,JPM calculates thatthe expected shareholder yield is 3.9%.This, as Dubravko concludes, \"is a significant cross-asset valuation support for equities at a time when 10yr US bonds are yielding 1.2% and $13 trillion of global debt has a negative yield.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":243,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":179437289,"gmtCreate":1626570738141,"gmtModify":1703761785190,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"Good news","listText":"Good news","text":"Good news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/179437289","repostId":"2152811496","repostType":4,"repost":{"id":"2152811496","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1626548760,"share":"https://ttm.financial/m/news/2152811496?lang=&edition=fundamental","pubTime":"2021-07-18 03:06","market":"hk","language":"en","title":"Pfizer is making the case for COVID-19 booster shots. Fauci say we don't need a third dose yet. Who's right?","url":"https://stock-news.laohu8.com/highlight/detail?id=2152811496","media":"Dow Jones","summary":"'I think people are hesitant to support booster dosing because at least for now it's unnecessary,' s","content":"<p>'I think people are hesitant to support booster dosing because at least for now it's unnecessary,' said Dr. Paul Offit, a vaccine expert</p>\n<p>A very public regulatory debate about COVID-19 booster shots has seemingly put Pfizer at odds with federal health officials who say it's not necessary to get another shot at this time.</p>\n<p>Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> last week reiterated plans to seek emergency authorization that tied waning protection from its vaccine to the more transmissible delta variant. The drug maker also said it's developing a booster specifically targeting delta, which is now thought to be the dominant strain of the virus in the U.S.</p>\n<p>Health officials and medical experts, on the other hand, continue to say there is no scientific case for COVID-19 boosters right now.</p>\n<p>\"I think people are hesitant to support booster dosing because at least for now it's unnecessary,\" Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia, told MarketWatch in an email.</p>\n<p>Dr. Anthony Fauci, chief medical adviser to President Joe Biden, on Sunday told CNN on Thursday saying something similar.</p>\n<p>And, in an email sent Friday afternoon and viewed by MarketWatch, National Institutes of Health director Dr. Francis Collins told staff that \"Pfizer seems to have gotten way out over their skis here,\" indicating that the company may be getting ahead of itself when it comes to boosters.</p>\n<p>But if the science evolves and it indicates that boosters are needed, that's going to present a new set of communication challenges for the Biden administration.</p>\n<p>\"It's distracting if people are getting an impression from statements from companies that they need\" to get a booster, said Dr. Lynn Goldman, an epidemiologist and dean of the Milken Institute School of Public Health at George Washington University. \"We're still trying to get people to immunize in the first place.\"</p>\n<p>The vaccination rate in the U.S. has flatlined at 48% . Telling people they need to get a third shot down line could lead to confusion, frustration, or an even more firm \"no\" from the hesitant.</p>\n<p>\"When you have so many Americans that are hesitant to get vaccinated, articulating to them that, 'Hey, the initial vaccines aren't going to be enough forever, and you're going to have to do this on a regular occurrence,' could make them more skeptical of the vaccines and less willing to get vaccinated initially,\" said Chris Meekins, a health policy analyst at Raymond James.</p>\n<p>The case for boosters is complicated</p>\n<p>Many public-health experts have said they expect booster doses will be necessary as immunity wanes and new variants emerge. However, much of that need is going to be based on when protection begins to diminish and in whom.</p>\n<p>Some experts believe booster shots will only be recommended for certain vulnerable segments of the population, like the elderly or people who are immunocompromised, and not for generally healthy Americans who want to reinforce the level of protection they already have. An influential CDC committee is expected to meet July 22 to discuss whether immunocompromised people need a booster shot.</p>\n<p>\"We believe the likely upcoming spike in cases and deaths may tip the balance\" in favor of boosters, RBC Capital Markets analyst Brian Abrahams told investors this week. \"Should a targeted booster approach be taken, we believe this provides evidence that immunosuppressed individuals and those with co-morbidities should be among the first dosed.\"</p>\n<p>This discussion is already playing out in other countries.</p>\n<p>A group of French doctors published a letter , outlining who can get a third shot depending on age, health status, and profession. Israel is now offering third doses to the immunocompromised.</p>\n<p>In the U.S., vaccine makers face a specific set of obstacles. One has to do with ensuring supply at a time when the authorized vaccines developed by Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a>, Moderna <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a>, and Pfizer are still bound by the requirements of the Defense Production Act, which can require companies based here to give priority to the U.S. during the public-health emergency.</p>\n<p>\"It looks like the pharmaceutical company is at odds with our federal health officials,\" said Dr. Leana Wen, an emergency room physician, \"when, actually, this is a matter of the pharmaceutical companies wanting to be prepared, wanting to have the boosters available, if and when they're needed.\"</p>\n<p>Moderna is studying booster doses, too. It announced a new deal in June with the U.S. for 200 million doses, \"which could be used for primary vaccination, including of children, or possibly as a booster if that becomes necessary to continue to defeat the pandemic,\" Moderna CEO Stéphane Bancel said in a news release. The company has signed agreements that could include booster shots with Argentina, Europe, Saudi Arabia, and Switzerland.</p>\n<p>Pfizer has not announced any deals that include boosters with the U.S.</p>\n<p>\"I think the company believes that it can garner public opinion to support a booster over people's fear of the most recent delta variant and are capitalizing on that opportunity to try to force the government in the direction they want it to go,\" Meekins said.</p>\n<p>How long does immunity from vaccines last?</p>\n<p>In a nutshell: We don't know. There are a still a number of unanswered questions about the \"durability\" of immunity.</p>\n<p>These include: What is the level of neutralizing antibody titers that still provide protection? Will T-cell response provide immunity if antibodies wane? When will we have a test that assesses antibody levels? When will the FDA establish a \"correlate\" of protection? Will only the most vulnerable people need a boost?</p>\n<p>To further complicate things, this is the first time we've had a vaccine for a coronavirus and the first time that mRNA shots have ever been deployed. Those factors create additional unknowns. And so without answers to some or all of these questions, we are largely stuck guessing.</p>\n<p>\"We basically are operating, in my view, in a fact-free zone,\" Goldman said. \"I don't think it at all irrational to get a EUA for boosters right now. I see the rationale. How we talk about it is a different issue.\"</p>\n<p>Pfizer recently said that immunity provided by its COVID-19 vaccine can wane six to 12 months after full vaccination; other officials believe the length of immunity is close to the tail end of that estimate, including the FDA's Dr. Peter Marks, who suggested in May that it's closer to at least <a href=\"https://laohu8.com/S/AONE.U\">one</a> year of protection.</p>\n<p>\"It's very unlikely that immunity is just going to fall off a cliff at some point,\" Wen said. \"More likely, you're going to see a gradual waning over time...And so I think that is part of the difficulty in translating these complicated messages to sound bites for the general public.\"</p>\n<p>See now:WHO head slams countries for ordering millions of COVID booster shots, when much of the world has not even vaccinated the most vulnerable</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer is making the case for COVID-19 booster shots. Fauci say we don't need a third dose yet. Who's right?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer is making the case for COVID-19 booster shots. Fauci say we don't need a third dose yet. Who's right?\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-07-18 03:06</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>'I think people are hesitant to support booster dosing because at least for now it's unnecessary,' said Dr. Paul Offit, a vaccine expert</p>\n<p>A very public regulatory debate about COVID-19 booster shots has seemingly put Pfizer at odds with federal health officials who say it's not necessary to get another shot at this time.</p>\n<p>Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> last week reiterated plans to seek emergency authorization that tied waning protection from its vaccine to the more transmissible delta variant. The drug maker also said it's developing a booster specifically targeting delta, which is now thought to be the dominant strain of the virus in the U.S.</p>\n<p>Health officials and medical experts, on the other hand, continue to say there is no scientific case for COVID-19 boosters right now.</p>\n<p>\"I think people are hesitant to support booster dosing because at least for now it's unnecessary,\" Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia, told MarketWatch in an email.</p>\n<p>Dr. Anthony Fauci, chief medical adviser to President Joe Biden, on Sunday told CNN on Thursday saying something similar.</p>\n<p>And, in an email sent Friday afternoon and viewed by MarketWatch, National Institutes of Health director Dr. Francis Collins told staff that \"Pfizer seems to have gotten way out over their skis here,\" indicating that the company may be getting ahead of itself when it comes to boosters.</p>\n<p>But if the science evolves and it indicates that boosters are needed, that's going to present a new set of communication challenges for the Biden administration.</p>\n<p>\"It's distracting if people are getting an impression from statements from companies that they need\" to get a booster, said Dr. Lynn Goldman, an epidemiologist and dean of the Milken Institute School of Public Health at George Washington University. \"We're still trying to get people to immunize in the first place.\"</p>\n<p>The vaccination rate in the U.S. has flatlined at 48% . Telling people they need to get a third shot down line could lead to confusion, frustration, or an even more firm \"no\" from the hesitant.</p>\n<p>\"When you have so many Americans that are hesitant to get vaccinated, articulating to them that, 'Hey, the initial vaccines aren't going to be enough forever, and you're going to have to do this on a regular occurrence,' could make them more skeptical of the vaccines and less willing to get vaccinated initially,\" said Chris Meekins, a health policy analyst at Raymond James.</p>\n<p>The case for boosters is complicated</p>\n<p>Many public-health experts have said they expect booster doses will be necessary as immunity wanes and new variants emerge. However, much of that need is going to be based on when protection begins to diminish and in whom.</p>\n<p>Some experts believe booster shots will only be recommended for certain vulnerable segments of the population, like the elderly or people who are immunocompromised, and not for generally healthy Americans who want to reinforce the level of protection they already have. An influential CDC committee is expected to meet July 22 to discuss whether immunocompromised people need a booster shot.</p>\n<p>\"We believe the likely upcoming spike in cases and deaths may tip the balance\" in favor of boosters, RBC Capital Markets analyst Brian Abrahams told investors this week. \"Should a targeted booster approach be taken, we believe this provides evidence that immunosuppressed individuals and those with co-morbidities should be among the first dosed.\"</p>\n<p>This discussion is already playing out in other countries.</p>\n<p>A group of French doctors published a letter , outlining who can get a third shot depending on age, health status, and profession. Israel is now offering third doses to the immunocompromised.</p>\n<p>In the U.S., vaccine makers face a specific set of obstacles. One has to do with ensuring supply at a time when the authorized vaccines developed by Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a>, Moderna <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a>, and Pfizer are still bound by the requirements of the Defense Production Act, which can require companies based here to give priority to the U.S. during the public-health emergency.</p>\n<p>\"It looks like the pharmaceutical company is at odds with our federal health officials,\" said Dr. Leana Wen, an emergency room physician, \"when, actually, this is a matter of the pharmaceutical companies wanting to be prepared, wanting to have the boosters available, if and when they're needed.\"</p>\n<p>Moderna is studying booster doses, too. It announced a new deal in June with the U.S. for 200 million doses, \"which could be used for primary vaccination, including of children, or possibly as a booster if that becomes necessary to continue to defeat the pandemic,\" Moderna CEO Stéphane Bancel said in a news release. The company has signed agreements that could include booster shots with Argentina, Europe, Saudi Arabia, and Switzerland.</p>\n<p>Pfizer has not announced any deals that include boosters with the U.S.</p>\n<p>\"I think the company believes that it can garner public opinion to support a booster over people's fear of the most recent delta variant and are capitalizing on that opportunity to try to force the government in the direction they want it to go,\" Meekins said.</p>\n<p>How long does immunity from vaccines last?</p>\n<p>In a nutshell: We don't know. There are a still a number of unanswered questions about the \"durability\" of immunity.</p>\n<p>These include: What is the level of neutralizing antibody titers that still provide protection? Will T-cell response provide immunity if antibodies wane? When will we have a test that assesses antibody levels? When will the FDA establish a \"correlate\" of protection? Will only the most vulnerable people need a boost?</p>\n<p>To further complicate things, this is the first time we've had a vaccine for a coronavirus and the first time that mRNA shots have ever been deployed. Those factors create additional unknowns. And so without answers to some or all of these questions, we are largely stuck guessing.</p>\n<p>\"We basically are operating, in my view, in a fact-free zone,\" Goldman said. \"I don't think it at all irrational to get a EUA for boosters right now. I see the rationale. How we talk about it is a different issue.\"</p>\n<p>Pfizer recently said that immunity provided by its COVID-19 vaccine can wane six to 12 months after full vaccination; other officials believe the length of immunity is close to the tail end of that estimate, including the FDA's Dr. Peter Marks, who suggested in May that it's closer to at least <a href=\"https://laohu8.com/S/AONE.U\">one</a> year of protection.</p>\n<p>\"It's very unlikely that immunity is just going to fall off a cliff at some point,\" Wen said. \"More likely, you're going to see a gradual waning over time...And so I think that is part of the difficulty in translating these complicated messages to sound bites for the general public.\"</p>\n<p>See now:WHO head slams countries for ordering millions of COVID booster shots, when much of the world has not even vaccinated the most vulnerable</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","MRNA":"Moderna, Inc.","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152811496","content_text":"'I think people are hesitant to support booster dosing because at least for now it's unnecessary,' said Dr. Paul Offit, a vaccine expert\nA very public regulatory debate about COVID-19 booster shots has seemingly put Pfizer at odds with federal health officials who say it's not necessary to get another shot at this time.\nPfizer $(PFE)$ last week reiterated plans to seek emergency authorization that tied waning protection from its vaccine to the more transmissible delta variant. The drug maker also said it's developing a booster specifically targeting delta, which is now thought to be the dominant strain of the virus in the U.S.\nHealth officials and medical experts, on the other hand, continue to say there is no scientific case for COVID-19 boosters right now.\n\"I think people are hesitant to support booster dosing because at least for now it's unnecessary,\" Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia, told MarketWatch in an email.\nDr. Anthony Fauci, chief medical adviser to President Joe Biden, on Sunday told CNN on Thursday saying something similar.\nAnd, in an email sent Friday afternoon and viewed by MarketWatch, National Institutes of Health director Dr. Francis Collins told staff that \"Pfizer seems to have gotten way out over their skis here,\" indicating that the company may be getting ahead of itself when it comes to boosters.\nBut if the science evolves and it indicates that boosters are needed, that's going to present a new set of communication challenges for the Biden administration.\n\"It's distracting if people are getting an impression from statements from companies that they need\" to get a booster, said Dr. Lynn Goldman, an epidemiologist and dean of the Milken Institute School of Public Health at George Washington University. \"We're still trying to get people to immunize in the first place.\"\nThe vaccination rate in the U.S. has flatlined at 48% . Telling people they need to get a third shot down line could lead to confusion, frustration, or an even more firm \"no\" from the hesitant.\n\"When you have so many Americans that are hesitant to get vaccinated, articulating to them that, 'Hey, the initial vaccines aren't going to be enough forever, and you're going to have to do this on a regular occurrence,' could make them more skeptical of the vaccines and less willing to get vaccinated initially,\" said Chris Meekins, a health policy analyst at Raymond James.\nThe case for boosters is complicated\nMany public-health experts have said they expect booster doses will be necessary as immunity wanes and new variants emerge. However, much of that need is going to be based on when protection begins to diminish and in whom.\nSome experts believe booster shots will only be recommended for certain vulnerable segments of the population, like the elderly or people who are immunocompromised, and not for generally healthy Americans who want to reinforce the level of protection they already have. An influential CDC committee is expected to meet July 22 to discuss whether immunocompromised people need a booster shot.\n\"We believe the likely upcoming spike in cases and deaths may tip the balance\" in favor of boosters, RBC Capital Markets analyst Brian Abrahams told investors this week. \"Should a targeted booster approach be taken, we believe this provides evidence that immunosuppressed individuals and those with co-morbidities should be among the first dosed.\"\nThis discussion is already playing out in other countries.\nA group of French doctors published a letter , outlining who can get a third shot depending on age, health status, and profession. Israel is now offering third doses to the immunocompromised.\nIn the U.S., vaccine makers face a specific set of obstacles. One has to do with ensuring supply at a time when the authorized vaccines developed by Johnson & Johnson $(JNJ)$, Moderna $(MRNA)$, and Pfizer are still bound by the requirements of the Defense Production Act, which can require companies based here to give priority to the U.S. during the public-health emergency.\n\"It looks like the pharmaceutical company is at odds with our federal health officials,\" said Dr. Leana Wen, an emergency room physician, \"when, actually, this is a matter of the pharmaceutical companies wanting to be prepared, wanting to have the boosters available, if and when they're needed.\"\nModerna is studying booster doses, too. It announced a new deal in June with the U.S. for 200 million doses, \"which could be used for primary vaccination, including of children, or possibly as a booster if that becomes necessary to continue to defeat the pandemic,\" Moderna CEO Stéphane Bancel said in a news release. The company has signed agreements that could include booster shots with Argentina, Europe, Saudi Arabia, and Switzerland.\nPfizer has not announced any deals that include boosters with the U.S.\n\"I think the company believes that it can garner public opinion to support a booster over people's fear of the most recent delta variant and are capitalizing on that opportunity to try to force the government in the direction they want it to go,\" Meekins said.\nHow long does immunity from vaccines last?\nIn a nutshell: We don't know. There are a still a number of unanswered questions about the \"durability\" of immunity.\nThese include: What is the level of neutralizing antibody titers that still provide protection? Will T-cell response provide immunity if antibodies wane? When will we have a test that assesses antibody levels? When will the FDA establish a \"correlate\" of protection? Will only the most vulnerable people need a boost?\nTo further complicate things, this is the first time we've had a vaccine for a coronavirus and the first time that mRNA shots have ever been deployed. Those factors create additional unknowns. And so without answers to some or all of these questions, we are largely stuck guessing.\n\"We basically are operating, in my view, in a fact-free zone,\" Goldman said. \"I don't think it at all irrational to get a EUA for boosters right now. I see the rationale. How we talk about it is a different issue.\"\nPfizer recently said that immunity provided by its COVID-19 vaccine can wane six to 12 months after full vaccination; other officials believe the length of immunity is close to the tail end of that estimate, including the FDA's Dr. Peter Marks, who suggested in May that it's closer to at least one year of protection.\n\"It's very unlikely that immunity is just going to fall off a cliff at some point,\" Wen said. \"More likely, you're going to see a gradual waning over time...And so I think that is part of the difficulty in translating these complicated messages to sound bites for the general public.\"\nSee now:WHO head slams countries for ordering millions of COVID booster shots, when much of the world has not even vaccinated the most vulnerable","news_type":1},"isVote":1,"tweetType":1,"viewCount":264,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":179432144,"gmtCreate":1626570510988,"gmtModify":1703761780186,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"Thanks for sharing","listText":"Thanks for sharing","text":"Thanks for sharing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/179432144","repostId":"2152368129","repostType":4,"isVote":1,"tweetType":1,"viewCount":185,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":175406147,"gmtCreate":1627044907589,"gmtModify":1703483128846,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"China always learn when they copy others country and they will turn the technology into a new way of transform.","listText":"China always learn when they copy others country and they will turn the technology into a new way of transform.","text":"China always learn when they copy others country and they will turn the technology into a new way of transform.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/175406147","repostId":"2153092983","repostType":4,"isVote":1,"tweetType":1,"viewCount":229,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":805046864,"gmtCreate":1627828467758,"gmtModify":1703496349225,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"Just buy it if you bhad strong conviction on SKLz","listText":"Just buy it if you bhad strong conviction on SKLz","text":"Just buy it if you bhad strong conviction on SKLz","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/805046864","repostId":"1146192957","repostType":4,"repost":{"id":"1146192957","kind":"news","pubTimestamp":1627783930,"share":"https://ttm.financial/m/news/1146192957?lang=&edition=fundamental","pubTime":"2021-08-01 10:12","market":"us","language":"en","title":"Upcoming Earnings Could Bring Back Positive Sentiment for Skillz","url":"https://stock-news.laohu8.com/highlight/detail?id=1146192957","media":"InvestorPlace","summary":"Next week's quarterly numbers could put SKLZ stock back on an upwards trajectory.\n\nSkillz(NYSE:SKLZ)","content":"<blockquote>\n <b>Next week's quarterly numbers could put SKLZ stock back on an upwards trajectory.</b>\n</blockquote>\n<p><b>Skillz</b>(NYSE:<b><u>SKLZ</u></b>) stock has been attempting to recover since May. Some investors dove in because it was a short-squeeze stock. Others bought it for its still-strong growth prospects. But in the past few weeks, SKLZ stock has pulled back once again.</p>\n<p>The latest round of “meme stock madness” has dissipated, and Reddit traders have bailed out of their Skillz shares. Concerns about possible interest rate hikes have also led to bearishness around growth stocks. Both of these factors played a role in knocking SKLZ stock back down to its prior price levels.</p>\n<p>Negative sentiment for Skillz may be on the rise. Yet you still may want to buy it ahead of its next quarterly earnings, which arescheduled to releaseafter the market closes on Aug 3. Just like last quarter, losses could come in higher than expected. But if its sales come in above forecast and management raises 2021 guidance once again, it may be enough to renew investors’ enthusiasm for SKLZ stock.</p>\n<p>Admittedly, its valuation is still a concern. Like other growth stocks, worries about rising rates could give way to multiple contraction. But if you’re confident in its “story,” buying Skillz stock at today’s price may be a solid “buy the dip” situation.</p>\n<p><b>SKLZ Stock and Its Upcoming Earnings Release</b></p>\n<p>As Skillz is not expected to be profitable until it scales up, earnings-per-share (EPS) is not a focus with next week’s earnings release. Instead, investors should look for revenue numbers and any updates to its 2021 guidance.</p>\n<p>Will it meet (or beat) analyst revenue consensus for the quarter ending June 30, 2021? Average revenue estimates for last quarter currently stand at$88.2 million. As<i>InvestorPlace’s</i>Mark Hake discussed July 22, it beat revenue estimates andupped its full-year guidancelast quarter.</p>\n<p>Some may anticipate this happening again. But based on the performance of SKLZ stock over the past month, that’s not the majority opinion.</p>\n<p>In July, shares pulled back more than 30%. Yet this lack of enthusiasm could be a positive for investors bullish on SKLZ stock. Possibly oversold at $14 per share, it could bounce back to $20 per share if its latest results exceed expectations.</p>\n<p>On the other hand, if the company disappoints for the quarter, the stock could get hammered once again. Its valuation is also a risk, so solid results and upgraded guidance may not be enough to keep shares steady, let alone raise them to previous highs.</p>\n<p><b>Caution May Be Needed Even With Strong Results</b></p>\n<p>Obviously, a revenue miss for this richly-priced stock (shares currently trade for 20.4x estimated 2021 sales) would mean big declines ahead. So would any change to the company’s guidance. But that’s not to say it’s all smooth sailing from here if the company beats on sales and positively revises its 2021 forecast.</p>\n<p>Factors that are not company-specific could have a negative impact on the price of SKLZ stock. The first that comes to mind is a possible hike in interest rates. How far could shares sink if multiple contraction continues for growth stocks?</p>\n<p>More mature names in the mobile games space, like<b>Zynga</b>(NASDAQ:<b><u>ZNGA</u></b>), trade at price-to-sales (P/S) ratios in the mid-single digits. Therefore, Skillz’s valuation could fall to high-single digits and still reflect the company’s higher-than-average growth. The issue is that a contraction like this implies a possible 50% in downside from today’s prices.</p>\n<p>Putting it simply, this stock could see a big move higher if its latest earnings beat expectations, but a multiple contraction could have an outsized effect on it as well.</p>\n<p><b>SKLZ Stock May Be Worth the Risk</b></p>\n<p><i>InvestorPlace’s</i>Luke Lango haslaid out the bull casefor SKLZ stock, and his argument is compelling. The company’s mobile gaming platform stands to gain massively if its tournament-based revenue model replaces traditional advertising-based models.</p>\n<p>Next week’s earnings results could remind investors, who have grown more bearish on Skillz in recent weeks, that high growth remains on the menu. This could mean a rapid move back to $20 or more in the short term.</p>\n<p>Granted, its high valuation remains a risk. Shares could fall 50% and still trade at a premium valuation. But if you believe these concerns are overblown and positive sentiment will return, buying SKLZ stock today may be worth it.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Upcoming Earnings Could Bring Back Positive Sentiment for Skillz</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUpcoming Earnings Could Bring Back Positive Sentiment for Skillz\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-01 10:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/07/sklz-stock-upcoming-earnings-could-bring-back-positive-sentiment/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Next week's quarterly numbers could put SKLZ stock back on an upwards trajectory.\n\nSkillz(NYSE:SKLZ) stock has been attempting to recover since May. Some investors dove in because it was a short-...</p>\n\n<a href=\"https://investorplace.com/2021/07/sklz-stock-upcoming-earnings-could-bring-back-positive-sentiment/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SKLZ":"Skillz Inc"},"source_url":"https://investorplace.com/2021/07/sklz-stock-upcoming-earnings-could-bring-back-positive-sentiment/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146192957","content_text":"Next week's quarterly numbers could put SKLZ stock back on an upwards trajectory.\n\nSkillz(NYSE:SKLZ) stock has been attempting to recover since May. Some investors dove in because it was a short-squeeze stock. Others bought it for its still-strong growth prospects. But in the past few weeks, SKLZ stock has pulled back once again.\nThe latest round of “meme stock madness” has dissipated, and Reddit traders have bailed out of their Skillz shares. Concerns about possible interest rate hikes have also led to bearishness around growth stocks. Both of these factors played a role in knocking SKLZ stock back down to its prior price levels.\nNegative sentiment for Skillz may be on the rise. Yet you still may want to buy it ahead of its next quarterly earnings, which arescheduled to releaseafter the market closes on Aug 3. Just like last quarter, losses could come in higher than expected. But if its sales come in above forecast and management raises 2021 guidance once again, it may be enough to renew investors’ enthusiasm for SKLZ stock.\nAdmittedly, its valuation is still a concern. Like other growth stocks, worries about rising rates could give way to multiple contraction. But if you’re confident in its “story,” buying Skillz stock at today’s price may be a solid “buy the dip” situation.\nSKLZ Stock and Its Upcoming Earnings Release\nAs Skillz is not expected to be profitable until it scales up, earnings-per-share (EPS) is not a focus with next week’s earnings release. Instead, investors should look for revenue numbers and any updates to its 2021 guidance.\nWill it meet (or beat) analyst revenue consensus for the quarter ending June 30, 2021? Average revenue estimates for last quarter currently stand at$88.2 million. AsInvestorPlace’sMark Hake discussed July 22, it beat revenue estimates andupped its full-year guidancelast quarter.\nSome may anticipate this happening again. But based on the performance of SKLZ stock over the past month, that’s not the majority opinion.\nIn July, shares pulled back more than 30%. Yet this lack of enthusiasm could be a positive for investors bullish on SKLZ stock. Possibly oversold at $14 per share, it could bounce back to $20 per share if its latest results exceed expectations.\nOn the other hand, if the company disappoints for the quarter, the stock could get hammered once again. Its valuation is also a risk, so solid results and upgraded guidance may not be enough to keep shares steady, let alone raise them to previous highs.\nCaution May Be Needed Even With Strong Results\nObviously, a revenue miss for this richly-priced stock (shares currently trade for 20.4x estimated 2021 sales) would mean big declines ahead. So would any change to the company’s guidance. But that’s not to say it’s all smooth sailing from here if the company beats on sales and positively revises its 2021 forecast.\nFactors that are not company-specific could have a negative impact on the price of SKLZ stock. The first that comes to mind is a possible hike in interest rates. How far could shares sink if multiple contraction continues for growth stocks?\nMore mature names in the mobile games space, likeZynga(NASDAQ:ZNGA), trade at price-to-sales (P/S) ratios in the mid-single digits. Therefore, Skillz’s valuation could fall to high-single digits and still reflect the company’s higher-than-average growth. The issue is that a contraction like this implies a possible 50% in downside from today’s prices.\nPutting it simply, this stock could see a big move higher if its latest earnings beat expectations, but a multiple contraction could have an outsized effect on it as well.\nSKLZ Stock May Be Worth the Risk\nInvestorPlace’sLuke Lango haslaid out the bull casefor SKLZ stock, and his argument is compelling. The company’s mobile gaming platform stands to gain massively if its tournament-based revenue model replaces traditional advertising-based models.\nNext week’s earnings results could remind investors, who have grown more bearish on Skillz in recent weeks, that high growth remains on the menu. This could mean a rapid move back to $20 or more in the short term.\nGranted, its high valuation remains a risk. Shares could fall 50% and still trade at a premium valuation. But if you believe these concerns are overblown and positive sentiment will return, buying SKLZ stock today may be worth it.","news_type":1},"isVote":1,"tweetType":1,"viewCount":214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":179432144,"gmtCreate":1626570510988,"gmtModify":1703761780186,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"Thanks for sharing","listText":"Thanks for sharing","text":"Thanks for sharing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/179432144","repostId":"2152368129","repostType":4,"isVote":1,"tweetType":1,"viewCount":185,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":816705172,"gmtCreate":1630532276196,"gmtModify":1676530329368,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>karching","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>karching","text":"$Tiger Brokers(TIGR)$karching","images":[{"img":"https://static.tigerbbs.com/73457e951d9f60b1ed007a5856bfa0c4","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/816705172","isVote":1,"tweetType":1,"viewCount":195,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":175405946,"gmtCreate":1627044984985,"gmtModify":1703483132138,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"This is too risky for investment, this is gambling","listText":"This is too risky for investment, this is gambling","text":"This is too risky for investment, this is gambling","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/175405946","repostId":"1123210107","repostType":4,"isVote":1,"tweetType":1,"viewCount":405,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":175409758,"gmtCreate":1627044794374,"gmtModify":1703483124564,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"China is looking in a long term view. Fabulous","listText":"China is looking in a long term view. Fabulous","text":"China is looking in a long term view. Fabulous","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/175409758","repostId":"1193325824","repostType":4,"isVote":1,"tweetType":1,"viewCount":140,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":179437289,"gmtCreate":1626570738141,"gmtModify":1703761785190,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"Good news","listText":"Good news","text":"Good news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/179437289","repostId":"2152811496","repostType":4,"repost":{"id":"2152811496","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1626548760,"share":"https://ttm.financial/m/news/2152811496?lang=&edition=fundamental","pubTime":"2021-07-18 03:06","market":"hk","language":"en","title":"Pfizer is making the case for COVID-19 booster shots. Fauci say we don't need a third dose yet. Who's right?","url":"https://stock-news.laohu8.com/highlight/detail?id=2152811496","media":"Dow Jones","summary":"'I think people are hesitant to support booster dosing because at least for now it's unnecessary,' s","content":"<p>'I think people are hesitant to support booster dosing because at least for now it's unnecessary,' said Dr. Paul Offit, a vaccine expert</p>\n<p>A very public regulatory debate about COVID-19 booster shots has seemingly put Pfizer at odds with federal health officials who say it's not necessary to get another shot at this time.</p>\n<p>Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> last week reiterated plans to seek emergency authorization that tied waning protection from its vaccine to the more transmissible delta variant. The drug maker also said it's developing a booster specifically targeting delta, which is now thought to be the dominant strain of the virus in the U.S.</p>\n<p>Health officials and medical experts, on the other hand, continue to say there is no scientific case for COVID-19 boosters right now.</p>\n<p>\"I think people are hesitant to support booster dosing because at least for now it's unnecessary,\" Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia, told MarketWatch in an email.</p>\n<p>Dr. Anthony Fauci, chief medical adviser to President Joe Biden, on Sunday told CNN on Thursday saying something similar.</p>\n<p>And, in an email sent Friday afternoon and viewed by MarketWatch, National Institutes of Health director Dr. Francis Collins told staff that \"Pfizer seems to have gotten way out over their skis here,\" indicating that the company may be getting ahead of itself when it comes to boosters.</p>\n<p>But if the science evolves and it indicates that boosters are needed, that's going to present a new set of communication challenges for the Biden administration.</p>\n<p>\"It's distracting if people are getting an impression from statements from companies that they need\" to get a booster, said Dr. Lynn Goldman, an epidemiologist and dean of the Milken Institute School of Public Health at George Washington University. \"We're still trying to get people to immunize in the first place.\"</p>\n<p>The vaccination rate in the U.S. has flatlined at 48% . Telling people they need to get a third shot down line could lead to confusion, frustration, or an even more firm \"no\" from the hesitant.</p>\n<p>\"When you have so many Americans that are hesitant to get vaccinated, articulating to them that, 'Hey, the initial vaccines aren't going to be enough forever, and you're going to have to do this on a regular occurrence,' could make them more skeptical of the vaccines and less willing to get vaccinated initially,\" said Chris Meekins, a health policy analyst at Raymond James.</p>\n<p>The case for boosters is complicated</p>\n<p>Many public-health experts have said they expect booster doses will be necessary as immunity wanes and new variants emerge. However, much of that need is going to be based on when protection begins to diminish and in whom.</p>\n<p>Some experts believe booster shots will only be recommended for certain vulnerable segments of the population, like the elderly or people who are immunocompromised, and not for generally healthy Americans who want to reinforce the level of protection they already have. An influential CDC committee is expected to meet July 22 to discuss whether immunocompromised people need a booster shot.</p>\n<p>\"We believe the likely upcoming spike in cases and deaths may tip the balance\" in favor of boosters, RBC Capital Markets analyst Brian Abrahams told investors this week. \"Should a targeted booster approach be taken, we believe this provides evidence that immunosuppressed individuals and those with co-morbidities should be among the first dosed.\"</p>\n<p>This discussion is already playing out in other countries.</p>\n<p>A group of French doctors published a letter , outlining who can get a third shot depending on age, health status, and profession. Israel is now offering third doses to the immunocompromised.</p>\n<p>In the U.S., vaccine makers face a specific set of obstacles. One has to do with ensuring supply at a time when the authorized vaccines developed by Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a>, Moderna <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a>, and Pfizer are still bound by the requirements of the Defense Production Act, which can require companies based here to give priority to the U.S. during the public-health emergency.</p>\n<p>\"It looks like the pharmaceutical company is at odds with our federal health officials,\" said Dr. Leana Wen, an emergency room physician, \"when, actually, this is a matter of the pharmaceutical companies wanting to be prepared, wanting to have the boosters available, if and when they're needed.\"</p>\n<p>Moderna is studying booster doses, too. It announced a new deal in June with the U.S. for 200 million doses, \"which could be used for primary vaccination, including of children, or possibly as a booster if that becomes necessary to continue to defeat the pandemic,\" Moderna CEO Stéphane Bancel said in a news release. The company has signed agreements that could include booster shots with Argentina, Europe, Saudi Arabia, and Switzerland.</p>\n<p>Pfizer has not announced any deals that include boosters with the U.S.</p>\n<p>\"I think the company believes that it can garner public opinion to support a booster over people's fear of the most recent delta variant and are capitalizing on that opportunity to try to force the government in the direction they want it to go,\" Meekins said.</p>\n<p>How long does immunity from vaccines last?</p>\n<p>In a nutshell: We don't know. There are a still a number of unanswered questions about the \"durability\" of immunity.</p>\n<p>These include: What is the level of neutralizing antibody titers that still provide protection? Will T-cell response provide immunity if antibodies wane? When will we have a test that assesses antibody levels? When will the FDA establish a \"correlate\" of protection? Will only the most vulnerable people need a boost?</p>\n<p>To further complicate things, this is the first time we've had a vaccine for a coronavirus and the first time that mRNA shots have ever been deployed. Those factors create additional unknowns. And so without answers to some or all of these questions, we are largely stuck guessing.</p>\n<p>\"We basically are operating, in my view, in a fact-free zone,\" Goldman said. \"I don't think it at all irrational to get a EUA for boosters right now. I see the rationale. How we talk about it is a different issue.\"</p>\n<p>Pfizer recently said that immunity provided by its COVID-19 vaccine can wane six to 12 months after full vaccination; other officials believe the length of immunity is close to the tail end of that estimate, including the FDA's Dr. Peter Marks, who suggested in May that it's closer to at least <a href=\"https://laohu8.com/S/AONE.U\">one</a> year of protection.</p>\n<p>\"It's very unlikely that immunity is just going to fall off a cliff at some point,\" Wen said. \"More likely, you're going to see a gradual waning over time...And so I think that is part of the difficulty in translating these complicated messages to sound bites for the general public.\"</p>\n<p>See now:WHO head slams countries for ordering millions of COVID booster shots, when much of the world has not even vaccinated the most vulnerable</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer is making the case for COVID-19 booster shots. Fauci say we don't need a third dose yet. Who's right?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer is making the case for COVID-19 booster shots. Fauci say we don't need a third dose yet. Who's right?\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-07-18 03:06</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>'I think people are hesitant to support booster dosing because at least for now it's unnecessary,' said Dr. Paul Offit, a vaccine expert</p>\n<p>A very public regulatory debate about COVID-19 booster shots has seemingly put Pfizer at odds with federal health officials who say it's not necessary to get another shot at this time.</p>\n<p>Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> last week reiterated plans to seek emergency authorization that tied waning protection from its vaccine to the more transmissible delta variant. The drug maker also said it's developing a booster specifically targeting delta, which is now thought to be the dominant strain of the virus in the U.S.</p>\n<p>Health officials and medical experts, on the other hand, continue to say there is no scientific case for COVID-19 boosters right now.</p>\n<p>\"I think people are hesitant to support booster dosing because at least for now it's unnecessary,\" Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia, told MarketWatch in an email.</p>\n<p>Dr. Anthony Fauci, chief medical adviser to President Joe Biden, on Sunday told CNN on Thursday saying something similar.</p>\n<p>And, in an email sent Friday afternoon and viewed by MarketWatch, National Institutes of Health director Dr. Francis Collins told staff that \"Pfizer seems to have gotten way out over their skis here,\" indicating that the company may be getting ahead of itself when it comes to boosters.</p>\n<p>But if the science evolves and it indicates that boosters are needed, that's going to present a new set of communication challenges for the Biden administration.</p>\n<p>\"It's distracting if people are getting an impression from statements from companies that they need\" to get a booster, said Dr. Lynn Goldman, an epidemiologist and dean of the Milken Institute School of Public Health at George Washington University. \"We're still trying to get people to immunize in the first place.\"</p>\n<p>The vaccination rate in the U.S. has flatlined at 48% . Telling people they need to get a third shot down line could lead to confusion, frustration, or an even more firm \"no\" from the hesitant.</p>\n<p>\"When you have so many Americans that are hesitant to get vaccinated, articulating to them that, 'Hey, the initial vaccines aren't going to be enough forever, and you're going to have to do this on a regular occurrence,' could make them more skeptical of the vaccines and less willing to get vaccinated initially,\" said Chris Meekins, a health policy analyst at Raymond James.</p>\n<p>The case for boosters is complicated</p>\n<p>Many public-health experts have said they expect booster doses will be necessary as immunity wanes and new variants emerge. However, much of that need is going to be based on when protection begins to diminish and in whom.</p>\n<p>Some experts believe booster shots will only be recommended for certain vulnerable segments of the population, like the elderly or people who are immunocompromised, and not for generally healthy Americans who want to reinforce the level of protection they already have. An influential CDC committee is expected to meet July 22 to discuss whether immunocompromised people need a booster shot.</p>\n<p>\"We believe the likely upcoming spike in cases and deaths may tip the balance\" in favor of boosters, RBC Capital Markets analyst Brian Abrahams told investors this week. \"Should a targeted booster approach be taken, we believe this provides evidence that immunosuppressed individuals and those with co-morbidities should be among the first dosed.\"</p>\n<p>This discussion is already playing out in other countries.</p>\n<p>A group of French doctors published a letter , outlining who can get a third shot depending on age, health status, and profession. Israel is now offering third doses to the immunocompromised.</p>\n<p>In the U.S., vaccine makers face a specific set of obstacles. One has to do with ensuring supply at a time when the authorized vaccines developed by Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a>, Moderna <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a>, and Pfizer are still bound by the requirements of the Defense Production Act, which can require companies based here to give priority to the U.S. during the public-health emergency.</p>\n<p>\"It looks like the pharmaceutical company is at odds with our federal health officials,\" said Dr. Leana Wen, an emergency room physician, \"when, actually, this is a matter of the pharmaceutical companies wanting to be prepared, wanting to have the boosters available, if and when they're needed.\"</p>\n<p>Moderna is studying booster doses, too. It announced a new deal in June with the U.S. for 200 million doses, \"which could be used for primary vaccination, including of children, or possibly as a booster if that becomes necessary to continue to defeat the pandemic,\" Moderna CEO Stéphane Bancel said in a news release. The company has signed agreements that could include booster shots with Argentina, Europe, Saudi Arabia, and Switzerland.</p>\n<p>Pfizer has not announced any deals that include boosters with the U.S.</p>\n<p>\"I think the company believes that it can garner public opinion to support a booster over people's fear of the most recent delta variant and are capitalizing on that opportunity to try to force the government in the direction they want it to go,\" Meekins said.</p>\n<p>How long does immunity from vaccines last?</p>\n<p>In a nutshell: We don't know. There are a still a number of unanswered questions about the \"durability\" of immunity.</p>\n<p>These include: What is the level of neutralizing antibody titers that still provide protection? Will T-cell response provide immunity if antibodies wane? When will we have a test that assesses antibody levels? When will the FDA establish a \"correlate\" of protection? Will only the most vulnerable people need a boost?</p>\n<p>To further complicate things, this is the first time we've had a vaccine for a coronavirus and the first time that mRNA shots have ever been deployed. Those factors create additional unknowns. And so without answers to some or all of these questions, we are largely stuck guessing.</p>\n<p>\"We basically are operating, in my view, in a fact-free zone,\" Goldman said. \"I don't think it at all irrational to get a EUA for boosters right now. I see the rationale. How we talk about it is a different issue.\"</p>\n<p>Pfizer recently said that immunity provided by its COVID-19 vaccine can wane six to 12 months after full vaccination; other officials believe the length of immunity is close to the tail end of that estimate, including the FDA's Dr. Peter Marks, who suggested in May that it's closer to at least <a href=\"https://laohu8.com/S/AONE.U\">one</a> year of protection.</p>\n<p>\"It's very unlikely that immunity is just going to fall off a cliff at some point,\" Wen said. \"More likely, you're going to see a gradual waning over time...And so I think that is part of the difficulty in translating these complicated messages to sound bites for the general public.\"</p>\n<p>See now:WHO head slams countries for ordering millions of COVID booster shots, when much of the world has not even vaccinated the most vulnerable</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","MRNA":"Moderna, Inc.","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152811496","content_text":"'I think people are hesitant to support booster dosing because at least for now it's unnecessary,' said Dr. Paul Offit, a vaccine expert\nA very public regulatory debate about COVID-19 booster shots has seemingly put Pfizer at odds with federal health officials who say it's not necessary to get another shot at this time.\nPfizer $(PFE)$ last week reiterated plans to seek emergency authorization that tied waning protection from its vaccine to the more transmissible delta variant. The drug maker also said it's developing a booster specifically targeting delta, which is now thought to be the dominant strain of the virus in the U.S.\nHealth officials and medical experts, on the other hand, continue to say there is no scientific case for COVID-19 boosters right now.\n\"I think people are hesitant to support booster dosing because at least for now it's unnecessary,\" Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia, told MarketWatch in an email.\nDr. Anthony Fauci, chief medical adviser to President Joe Biden, on Sunday told CNN on Thursday saying something similar.\nAnd, in an email sent Friday afternoon and viewed by MarketWatch, National Institutes of Health director Dr. Francis Collins told staff that \"Pfizer seems to have gotten way out over their skis here,\" indicating that the company may be getting ahead of itself when it comes to boosters.\nBut if the science evolves and it indicates that boosters are needed, that's going to present a new set of communication challenges for the Biden administration.\n\"It's distracting if people are getting an impression from statements from companies that they need\" to get a booster, said Dr. Lynn Goldman, an epidemiologist and dean of the Milken Institute School of Public Health at George Washington University. \"We're still trying to get people to immunize in the first place.\"\nThe vaccination rate in the U.S. has flatlined at 48% . Telling people they need to get a third shot down line could lead to confusion, frustration, or an even more firm \"no\" from the hesitant.\n\"When you have so many Americans that are hesitant to get vaccinated, articulating to them that, 'Hey, the initial vaccines aren't going to be enough forever, and you're going to have to do this on a regular occurrence,' could make them more skeptical of the vaccines and less willing to get vaccinated initially,\" said Chris Meekins, a health policy analyst at Raymond James.\nThe case for boosters is complicated\nMany public-health experts have said they expect booster doses will be necessary as immunity wanes and new variants emerge. However, much of that need is going to be based on when protection begins to diminish and in whom.\nSome experts believe booster shots will only be recommended for certain vulnerable segments of the population, like the elderly or people who are immunocompromised, and not for generally healthy Americans who want to reinforce the level of protection they already have. An influential CDC committee is expected to meet July 22 to discuss whether immunocompromised people need a booster shot.\n\"We believe the likely upcoming spike in cases and deaths may tip the balance\" in favor of boosters, RBC Capital Markets analyst Brian Abrahams told investors this week. \"Should a targeted booster approach be taken, we believe this provides evidence that immunosuppressed individuals and those with co-morbidities should be among the first dosed.\"\nThis discussion is already playing out in other countries.\nA group of French doctors published a letter , outlining who can get a third shot depending on age, health status, and profession. Israel is now offering third doses to the immunocompromised.\nIn the U.S., vaccine makers face a specific set of obstacles. One has to do with ensuring supply at a time when the authorized vaccines developed by Johnson & Johnson $(JNJ)$, Moderna $(MRNA)$, and Pfizer are still bound by the requirements of the Defense Production Act, which can require companies based here to give priority to the U.S. during the public-health emergency.\n\"It looks like the pharmaceutical company is at odds with our federal health officials,\" said Dr. Leana Wen, an emergency room physician, \"when, actually, this is a matter of the pharmaceutical companies wanting to be prepared, wanting to have the boosters available, if and when they're needed.\"\nModerna is studying booster doses, too. It announced a new deal in June with the U.S. for 200 million doses, \"which could be used for primary vaccination, including of children, or possibly as a booster if that becomes necessary to continue to defeat the pandemic,\" Moderna CEO Stéphane Bancel said in a news release. The company has signed agreements that could include booster shots with Argentina, Europe, Saudi Arabia, and Switzerland.\nPfizer has not announced any deals that include boosters with the U.S.\n\"I think the company believes that it can garner public opinion to support a booster over people's fear of the most recent delta variant and are capitalizing on that opportunity to try to force the government in the direction they want it to go,\" Meekins said.\nHow long does immunity from vaccines last?\nIn a nutshell: We don't know. There are a still a number of unanswered questions about the \"durability\" of immunity.\nThese include: What is the level of neutralizing antibody titers that still provide protection? Will T-cell response provide immunity if antibodies wane? When will we have a test that assesses antibody levels? When will the FDA establish a \"correlate\" of protection? Will only the most vulnerable people need a boost?\nTo further complicate things, this is the first time we've had a vaccine for a coronavirus and the first time that mRNA shots have ever been deployed. Those factors create additional unknowns. And so without answers to some or all of these questions, we are largely stuck guessing.\n\"We basically are operating, in my view, in a fact-free zone,\" Goldman said. \"I don't think it at all irrational to get a EUA for boosters right now. I see the rationale. How we talk about it is a different issue.\"\nPfizer recently said that immunity provided by its COVID-19 vaccine can wane six to 12 months after full vaccination; other officials believe the length of immunity is close to the tail end of that estimate, including the FDA's Dr. Peter Marks, who suggested in May that it's closer to at least one year of protection.\n\"It's very unlikely that immunity is just going to fall off a cliff at some point,\" Wen said. \"More likely, you're going to see a gradual waning over time...And so I think that is part of the difficulty in translating these complicated messages to sound bites for the general public.\"\nSee now:WHO head slams countries for ordering millions of COVID booster shots, when much of the world has not even vaccinated the most vulnerable","news_type":1},"isVote":1,"tweetType":1,"viewCount":264,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176690118,"gmtCreate":1626878403634,"gmtModify":1703479855018,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"Fabulous","listText":"Fabulous","text":"Fabulous","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/176690118","repostId":"1107219983","repostType":4,"repost":{"id":"1107219983","kind":"news","pubTimestamp":1626858926,"share":"https://ttm.financial/m/news/1107219983?lang=&edition=fundamental","pubTime":"2021-07-21 17:15","market":"us","language":"en","title":"Here Is The One-Word Reason Why JPMorgan Just Raised Its S&P Target To 4,600","url":"https://stock-news.laohu8.com/highlight/detail?id=1107219983","media":"zerohedge","summary":"Mid-cycle?Late-cycle? Nope: according to the latest note published overnight from JPMorgan head glob","content":"<p>Mid-cycle?Late-cycle? Nope: according to the latest note published overnight from JPMorgan head global equity strategist Dubravko Lakos-Bujas, \"even though equity leadership and bonds are trading as if the global economy is entering late cycle,<b>our research suggests the recovery is still in early-cycle</b>and gradually transitioning towards mid-cycle.\" And echoing his JPM colleague and fellow Croat, Marko Kolanovic, who yesterdayadvised clients to stop freaking out about the delta variant(advise which markets are taking to heart today), Dubravko writes that the largest commercial bank remains \"constructive on equities and see the latest round of growth and slowdown fears premature and overblown.\"</p>\n<p><img src=\"https://static.tigerbbs.com/52b0923c42b8b316b85e56a776fa3337\" tg-width=\"1132\" tg-height=\"1215\" width=\"100%\" height=\"auto\">Elaborating on why he is sanguine about the current Delta case breakout, Lakos-Bujas writes that \"we remain of the view that this latest wave will not derail the broader reopening process. While cases have gone up, deaths / hospitalizations remain low and stable due to broadening vaccination rollout and self-immunity from prior waves.\"</p>\n<p><img src=\"https://static.tigerbbs.com/d396ca943f750f3a3bcb38e01a53cbdf\" tg-width=\"772\" tg-height=\"546\" width=\"100%\" height=\"auto\">The strategist then argues that \"reopening of the economy is not an event but rather a process, which in our opinion is still not priced-in, and especially not now given recent market moves. For instance, an increasing number of reopening stocks are now down 30-50% from 1Q21 highs (i.e. travel, cruise lines, oil) and some have reversed back to last year June levels when COVID-19 uncertainty and economic setup were vastly worse than today.\"</p>\n<p>Given the above, JPM sees \"increasingly compelling\" risk/reward for the reopening theme, which can be expressed through Consumer Recovery (JPAMCONR &lt;Index&gt;), Domestic Recovery (JPAMCRDB &lt;Index&gt;) and International Recovery (JPAMCRIB &lt;Index&gt;) baskets, see Fig 1.\" Additionally, JPm argues that global mobility remains nascent and its normalization will continue to release pent-up demand, while tight inventories and new orders bode positively for global growth.</p>\n<p><img src=\"https://static.tigerbbs.com/dc9c52172685e208ffe19abe53233205\" tg-width=\"958\" tg-height=\"959\" width=\"100%\" height=\"auto\">Combining all this bullishness,<b>the JPM equity strategist is revising his EPS estimates higher by an additional $5 to $205 for 2021 and raises the bank's long-held 2021 year-end price target of 4,400 to 4,600, due to the following considerations:</b></p>\n<blockquote>\n At a thematic/sector level, the risk/reward for reopening stocks has improved significantly with the recent pullback creating many unusually attractive opportunities for investors to re-enter various parts of the cyclical cohort. Consumer Discretionary (i.e. Retail, Travel &amp; Leisure), Semis, Banks and Energy are strong buys at current levels. For instance,\n <b>large-cap Energy is now trading at a ~10% FCF yield and a &gt;8% FCF/EV yield at $70 Brent in 2022, with leverage that is &lt;1x</b>. The sector has increasing potential for a sharp short squeeze and move higher, given its extreme disconnect from oil fundamentals (i.e. widest in 30+ years, Figure 10). In addition, our Semiconductor research argues that we are only 30-40% of the way into&nbsp; the current semiconductor upcycle and expect strong Y/Y growth into next year with positive EPS revisions for the next 3-4 quarters. Supply will likely remain tight into 2022, while demand remains strong (20-40% above companies’ ability to supply), thus this supply demand imbalance will persist through 2021. Although customers are responding to tight supply with higher than needed orders, ongoing supply tightness is limiting fulfillment. In fact, JPM expects channel and customer inventories to decline Q/Q again in the just completed June quarter.\n</blockquote>\n<p>Looking at the fundamentals, JPM predicts that S&amp;P 500 gains should also be supported by strong earnings growth and capital return until 2023,<b>and is why JPM is adjusting its above consensus S&amp;P 500 EPS by another $5 for 2022 to $230 (consensus $214) and 2023 to $250 (consensus $233).</b></p>\n<blockquote>\n This revision is largely due to global reopening which is delayed and bound to release further pent-up demand, inventory replenishment, rising profitability for Energy companies, and ongoing policy actions (childcare, infrastructure, etc). We expect cumulative revenue growth of ~30% by 2023 relative to pre-COVID (FY 2019), ~150bp net income margin expansion to a record high at over 13%, and gross buybacks nearing an annual pace of ~$1t during this period.\n</blockquote>\n<p>While all sectors are expected to contribute to earnings growth, JPM expects reflation sensitive sectors (Commodities, Financials, Industrials) and Consumer to do the heaviest lifting in the coming quarters in terms of beats and revisions.</p>\n<p>Putting it all together, Lakos-Bujas says that \"<b>considering this outlook for earnings and shareholder return, we are raising our Price Target to 4,600 for year-end 2021.\"</b></p>\n<p>But while any first year strategist can goalseek a fundamentally bullish narrative and chart it, as JPM has done below...</p>\n<p><img src=\"https://static.tigerbbs.com/41e87174356d968c69893caff66745e0\" tg-width=\"1072\" tg-height=\"1304\" width=\"100%\" height=\"auto\">... there is a very specific reason behind JPM's bullish reversal:<b>the coming surge in buybacks which will result in a boom in shareholder returns,</b>or as Dubravko notes, \"corporates have already increased gross buybacks from pandemic era low of $525b (trailing twelve months as of 1Q21) to an annualized run rate of ~$775b YTD and should surpass previous record of ~$850b (as of 1Q19).\"</p>\n<p><img src=\"https://static.tigerbbs.com/3b09d295af263e87277eaffbda47bb7c\" tg-width=\"1076\" tg-height=\"435\" width=\"100%\" height=\"auto\">In practical terms, JPM expects a sharp drop in the S&amp;P's share count in the next 24 months as the buyback-facilitated slow-motion LBO continues.</p>\n<p><img src=\"https://static.tigerbbs.com/ae94ad29f188e3aac5cdf92b9df65fc3\" tg-width=\"1048\" tg-height=\"396\" width=\"100%\" height=\"auto\">Some more details below on the one biggest catalyst behind JPM's SPX price target hike:</p>\n<blockquote>\n <b>Expecting a boom in shareholder return led by buybacks.</b>Buybacks are reemerging as a key theme with net buyback activity significantly improving this year after bottoming in 2Q20. Corporate buyback announcements, typically a leading indicator of buyback execution activity and corporate confidence, have already well-exceeded 2020 levels ($431B YTD vs. $307B 2020, see Figure 25). In fact,\n <b>the rebound in announcement activity is similar to the surge post-TCJA (see Figure 23) which is tracking towards and it is likely to easily surpass ~$650B by year-end and likely to see rolling 12-month announcements surpass prior record level of ~$1T.</b>Historically, buyback announcements have been concentrated within Technology and Financials. However, YTD we are seeing strong announcement activity from Communications as well (driven by GOOGL ~$50B in Apr). As a reminder, ~$90B of Tech’s $133B in announcements YTD is supported by AAPL and ~$25B of Financials' ~$92B is supported by BAC.\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/774d4e9c2550b27c62d10733947c8de4\" tg-width=\"1077\" tg-height=\"384\" width=\"100%\" height=\"auto\">With the June 30th lifting of pandemic era restriction on US Banks,<b>we could see some further pick-up in buyback announcements.</b>Dry powder (i.e. announced repurchase programs not yet executed) levels have been recovering to pre-pandemic levels (~$658B, see Figure 27) as executions have been relatively slower to rebound but should show a material sequential growth in the coming quarters. With record profit margins (~13% in 2022 vs ~11.5% in 2019), bloated cash levels of $2.0T ex-financials (vs. $1.6T pre- COVID), and lower high grade debt yields (JULI at 2.6% now, vs 3.3% prepandemic),<b>we are expecting a boom in buyback activity over the next year.</b>Gross buybacks should surpass the prior executed high of $850b.</p>\n<p><img src=\"https://static.tigerbbs.com/053354e7e2fc9ea74585b437e0d77f78\" tg-width=\"1076\" tg-height=\"415\" width=\"100%\" height=\"auto\">In summary,<i>assuming $875b in buybacks and dividend income of $575 over the next year,</i>JPM calculates that<b>the expected shareholder yield is 3.9%.</b>This, as Dubravko concludes, \"is a significant cross-asset valuation support for equities at a time when 10yr US bonds are yielding 1.2% and $13 trillion of global debt has a negative yield.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here Is The One-Word Reason Why JPMorgan Just Raised Its S&P Target To 4,600</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere Is The One-Word Reason Why JPMorgan Just Raised Its S&P Target To 4,600\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-21 17:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/here-one-word-reason-why-jpmorgan-just-raised-its-sp-target-4600><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Mid-cycle?Late-cycle? Nope: according to the latest note published overnight from JPMorgan head global equity strategist Dubravko Lakos-Bujas, \"even though equity leadership and bonds are trading as ...</p>\n\n<a href=\"https://www.zerohedge.com/markets/here-one-word-reason-why-jpmorgan-just-raised-its-sp-target-4600\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","SPY":"标普500ETF"},"source_url":"https://www.zerohedge.com/markets/here-one-word-reason-why-jpmorgan-just-raised-its-sp-target-4600","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107219983","content_text":"Mid-cycle?Late-cycle? Nope: according to the latest note published overnight from JPMorgan head global equity strategist Dubravko Lakos-Bujas, \"even though equity leadership and bonds are trading as if the global economy is entering late cycle,our research suggests the recovery is still in early-cycleand gradually transitioning towards mid-cycle.\" And echoing his JPM colleague and fellow Croat, Marko Kolanovic, who yesterdayadvised clients to stop freaking out about the delta variant(advise which markets are taking to heart today), Dubravko writes that the largest commercial bank remains \"constructive on equities and see the latest round of growth and slowdown fears premature and overblown.\"\nElaborating on why he is sanguine about the current Delta case breakout, Lakos-Bujas writes that \"we remain of the view that this latest wave will not derail the broader reopening process. While cases have gone up, deaths / hospitalizations remain low and stable due to broadening vaccination rollout and self-immunity from prior waves.\"\nThe strategist then argues that \"reopening of the economy is not an event but rather a process, which in our opinion is still not priced-in, and especially not now given recent market moves. For instance, an increasing number of reopening stocks are now down 30-50% from 1Q21 highs (i.e. travel, cruise lines, oil) and some have reversed back to last year June levels when COVID-19 uncertainty and economic setup were vastly worse than today.\"\nGiven the above, JPM sees \"increasingly compelling\" risk/reward for the reopening theme, which can be expressed through Consumer Recovery (JPAMCONR <Index>), Domestic Recovery (JPAMCRDB <Index>) and International Recovery (JPAMCRIB <Index>) baskets, see Fig 1.\" Additionally, JPm argues that global mobility remains nascent and its normalization will continue to release pent-up demand, while tight inventories and new orders bode positively for global growth.\nCombining all this bullishness,the JPM equity strategist is revising his EPS estimates higher by an additional $5 to $205 for 2021 and raises the bank's long-held 2021 year-end price target of 4,400 to 4,600, due to the following considerations:\n\n At a thematic/sector level, the risk/reward for reopening stocks has improved significantly with the recent pullback creating many unusually attractive opportunities for investors to re-enter various parts of the cyclical cohort. Consumer Discretionary (i.e. Retail, Travel & Leisure), Semis, Banks and Energy are strong buys at current levels. For instance,\n large-cap Energy is now trading at a ~10% FCF yield and a >8% FCF/EV yield at $70 Brent in 2022, with leverage that is <1x. The sector has increasing potential for a sharp short squeeze and move higher, given its extreme disconnect from oil fundamentals (i.e. widest in 30+ years, Figure 10). In addition, our Semiconductor research argues that we are only 30-40% of the way into  the current semiconductor upcycle and expect strong Y/Y growth into next year with positive EPS revisions for the next 3-4 quarters. Supply will likely remain tight into 2022, while demand remains strong (20-40% above companies’ ability to supply), thus this supply demand imbalance will persist through 2021. Although customers are responding to tight supply with higher than needed orders, ongoing supply tightness is limiting fulfillment. In fact, JPM expects channel and customer inventories to decline Q/Q again in the just completed June quarter.\n\nLooking at the fundamentals, JPM predicts that S&P 500 gains should also be supported by strong earnings growth and capital return until 2023,and is why JPM is adjusting its above consensus S&P 500 EPS by another $5 for 2022 to $230 (consensus $214) and 2023 to $250 (consensus $233).\n\n This revision is largely due to global reopening which is delayed and bound to release further pent-up demand, inventory replenishment, rising profitability for Energy companies, and ongoing policy actions (childcare, infrastructure, etc). We expect cumulative revenue growth of ~30% by 2023 relative to pre-COVID (FY 2019), ~150bp net income margin expansion to a record high at over 13%, and gross buybacks nearing an annual pace of ~$1t during this period.\n\nWhile all sectors are expected to contribute to earnings growth, JPM expects reflation sensitive sectors (Commodities, Financials, Industrials) and Consumer to do the heaviest lifting in the coming quarters in terms of beats and revisions.\nPutting it all together, Lakos-Bujas says that \"considering this outlook for earnings and shareholder return, we are raising our Price Target to 4,600 for year-end 2021.\"\nBut while any first year strategist can goalseek a fundamentally bullish narrative and chart it, as JPM has done below...\n... there is a very specific reason behind JPM's bullish reversal:the coming surge in buybacks which will result in a boom in shareholder returns,or as Dubravko notes, \"corporates have already increased gross buybacks from pandemic era low of $525b (trailing twelve months as of 1Q21) to an annualized run rate of ~$775b YTD and should surpass previous record of ~$850b (as of 1Q19).\"\nIn practical terms, JPM expects a sharp drop in the S&P's share count in the next 24 months as the buyback-facilitated slow-motion LBO continues.\nSome more details below on the one biggest catalyst behind JPM's SPX price target hike:\n\nExpecting a boom in shareholder return led by buybacks.Buybacks are reemerging as a key theme with net buyback activity significantly improving this year after bottoming in 2Q20. Corporate buyback announcements, typically a leading indicator of buyback execution activity and corporate confidence, have already well-exceeded 2020 levels ($431B YTD vs. $307B 2020, see Figure 25). In fact,\n the rebound in announcement activity is similar to the surge post-TCJA (see Figure 23) which is tracking towards and it is likely to easily surpass ~$650B by year-end and likely to see rolling 12-month announcements surpass prior record level of ~$1T.Historically, buyback announcements have been concentrated within Technology and Financials. However, YTD we are seeing strong announcement activity from Communications as well (driven by GOOGL ~$50B in Apr). As a reminder, ~$90B of Tech’s $133B in announcements YTD is supported by AAPL and ~$25B of Financials' ~$92B is supported by BAC.\n\nWith the June 30th lifting of pandemic era restriction on US Banks,we could see some further pick-up in buyback announcements.Dry powder (i.e. announced repurchase programs not yet executed) levels have been recovering to pre-pandemic levels (~$658B, see Figure 27) as executions have been relatively slower to rebound but should show a material sequential growth in the coming quarters. With record profit margins (~13% in 2022 vs ~11.5% in 2019), bloated cash levels of $2.0T ex-financials (vs. $1.6T pre- COVID), and lower high grade debt yields (JULI at 2.6% now, vs 3.3% prepandemic),we are expecting a boom in buyback activity over the next year.Gross buybacks should surpass the prior executed high of $850b.\nIn summary,assuming $875b in buybacks and dividend income of $575 over the next year,JPM calculates thatthe expected shareholder yield is 3.9%.This, as Dubravko concludes, \"is a significant cross-asset valuation support for equities at a time when 10yr US bonds are yielding 1.2% and $13 trillion of global debt has a negative yield.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":243,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":212651636023520,"gmtCreate":1692956743775,"gmtModify":1692956748377,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/212651636023520","repostId":"1133549138","repostType":2,"isVote":1,"tweetType":1,"viewCount":399,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":296233428578472,"gmtCreate":1713342796503,"gmtModify":1713342799753,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"Share your opinion about this news…","listText":"Share your opinion about this news…","text":"Share your opinion about this news…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/296233428578472","repostId":"1189337221","repostType":2,"isVote":1,"tweetType":1,"viewCount":67,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":869457976,"gmtCreate":1632318808095,"gmtModify":1676530751176,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"Hi here is the TA sharing regarding FVRR.From MACD line showing it uptrend. It could be a bullish if the MACD line break the zero reference.Currently the RSI at around 62. It means not too late to buy some share as a start up.If you see from the chart, the first support price range is around 190-200; second support price range is 155-165.And you put in EMA 100 Or 200, it will be shown the share still considered under value from TA basic.Strategy could be taken1)Sell put to get some premium as a start up to buy some share as a start up position. 2) Buy Call ATM -3 since it still at support level.( Do this only you had a strong conviction)","listText":"Hi here is the TA sharing regarding FVRR.From MACD line showing it uptrend. It could be a bullish if the MACD line break the zero reference.Currently the RSI at around 62. It means not too late to buy some share as a start up.If you see from the chart, the first support price range is around 190-200; second support price range is 155-165.And you put in EMA 100 Or 200, it will be shown the share still considered under value from TA basic.Strategy could be taken1)Sell put to get some premium as a start up to buy some share as a start up position. 2) Buy Call ATM -3 since it still at support level.( Do this only you had a strong conviction)","text":"Hi here is the TA sharing regarding FVRR.From MACD line showing it uptrend. It could be a bullish if the MACD line break the zero reference.Currently the RSI at around 62. It means not too late to buy some share as a start up.If you see from the chart, the first support price range is around 190-200; second support price range is 155-165.And you put in EMA 100 Or 200, it will be shown the share still considered under value from TA basic.Strategy could be taken1)Sell put to get some premium as a start up to buy some share as a start up position. 2) Buy Call ATM -3 since it still at support level.( Do this only you had a strong conviction)","images":[{"img":"https://static.tigerbbs.com/528ab93897562a336340ec489a5dc6b8","width":"1366","height":"768"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/869457976","isVote":1,"tweetType":1,"viewCount":294,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":244030409236704,"gmtCreate":1700601796748,"gmtModify":1700601800046,"author":{"id":"3564653723071869","authorId":"3564653723071869","name":"Siong25","avatar":"https://static.tigerbbs.com/1c76890997f9d9ddfa1a2edd67b99241","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564653723071869","authorIdStr":"3564653723071869"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$&nbsp;</a>","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$&nbsp;</a>","text":"$NVIDIA Corp(NVDA)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/244030409236704","isVote":1,"tweetType":1,"viewCount":248,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}